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ABSTRACT

MOLECULAR MECHANISMS OF
HEXAVALENT CHROMIUM-INDUCED
CENTROSOME AMPLIFICATION

Jennifer H. Toyoda
June 21, 2022

Lung cancer is the deadliest form of cancer and resulted in 1.8 million deaths
worldwide in 2020. While cigarette smoking is the most familiar cause of lung
cancer, up to 25% of cases occur in non-smokers, thus other environmental agents
are also causative. Hexavalent chromium [Cr(VI)] is a known lung carcinogen and
poses occupational and environmental exposure risks relevant to humans, wildlife,
and ecosystems. This dissertation considers the carcinogenic mechanisms of a
highly potent, particulate, hexavalent chromium compound, zinc chromate.
The molecular mechanism of carcinogenesis induced by Cr(VI) is not fully
understood, but it is known that chromosome instability is a key effect.
Chromosome instability refers to structural instability characterized by breaks and
translocations, and numerical instability characterized by changing numbers of
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chromosomes. This dissertation focuses on how hexavalent chromium causes
numerical chromosome instability in human lung cells and uses the One
Environmental Health approach to gain insights into the associated mechanism
using whale cells as a comparative model. The hypothesis of this project is:
Prolonged hexavalent chromium exposure targets securin in human lung cells,
leading to centrosome amplification and numerical chromosome instability, while
the ability of whale cells to retain normal securin levels confers resistance to these
effects.
A main driver of numerical chromosome instability is centrosome
amplification, defined in this study as a single cell with more than two centrosomes.
We previously found Cr(VI) induces centrosome amplification, which increased
with duration and concentration of exposure and correlated with Cr(VI)-induced
aneuploidy. In Aim 1 we focused on a novel potential target of Cr(VI), securin.
Securin is an important centrosome regulator because it is the canonical inhibitor
of separase. Separase is the enzyme that causes centriole disengagement and
permits centrosome duplication. Prolonged Cr(VI) exposure decreased securin
protein levels in a dose-dependent manner. Securin protein loss was not due to
changes in protein degradation, but rather a loss of securin mRNA. Three
measures of securin function were analyzed to determine if decreased securin
levels were sufficient to control separase activity. Separase cleaves itself, kendrin,
and

cohesin.

Prolonged

Cr(VI)

exposure

caused

increased

separase

autocleavage, increased kendrin cleavage, and increased separation at
centromeres caused by cohesin cleavage. Securin knockdown increased levels of
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aneuploidy after acute Cr(VI) exposure, in contrast to untransfected cells which
retained normal background levels. Together these data showed Cr(VI) disrupts
securin, a key protein in the maintenance of numerical chromosome stability.
Aim 2 sought to uncover the mechanism of Cr(VI)-induced securin loss
described in Aim 1. Transcription factors bind to gene promoter regions to enhance
or inhibit gene transcription and have been shown to be disrupted by Cr(VI). Thus,
we measured three securin-promoting transcription factors, Sp1, NF-YA, and
E2F1, and two repressing transcription factors, KLF6 and p53. Cr(VI) elevated
levels of securin-promoting factors in nuclear fractions, indicating Cr(VI) is not
repressing their levels to decrease securin expression. E2F1 was previously
shown to decrease with prolonged Cr(VI) exposure, but experimental knockdown
revealed E2F1 is not a driving factor for Cr(VI)-induced securin loss. Securin
expression loss was also not explained by p53 activation, as protein levels and
phosphorylation did not correlate with securin loss. KLF6 nuclear protein levels
were increased at prolonged timepoints, which may begin to explain reduction in
securin levels. MicroRNA (miRNA) regulation is altered by Cr(VI) and is a possible
mechanism for securin loss. Several miRNAs were found to be significantly upand down-regulated at all tested concentrations and timepoints. Securin was not
specifically targeted by any of the altered miRNAs. However, several centrosomeassociated proteins are putative targets of Cr(VI)-induced miRNA alteration.
The One Environmental Health approach acknowledges humans, wildlife,
and ecosystems are connected by a shared environment and common toxicants
such as Cr(VI). Aim 3 characterizes the effects of prolonged Cr(VI) exposure on
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whale cells. We measured securin levels and function in bowhead whale cells and
found securin levels remained normal under all exposure conditions and neither
premature centromere separation nor centrosome amplification were increased.
We found Cr(VI) did not cause aneuploidy in sperm whale or bowhead whale cells.
Interestingly, chromosome damage still occurred, indicating Cr(VI) is active inside
whale cells. These data indicate maintenance of securin under Cr(VI) exposure
may protect whale cells from developing centrosome amplification and numerical
chromosome instability.
Overall, this dissertation shows securin is targeted by prolonged Cr(VI)
exposure in human lung cells and centrosome regulation pathways are central in
the mechanism of Cr(VI) carcinogenesis. We showed whales are resistant to
securin loss and the proposed downstream phenotypes, centrosome amplification
and numerical chromosome instability. Together these data support the hypothesis
Cr(VI)-induced securin loss leads to numerical chromosome instability.
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CHAPTER 1: INTRODUCTION

Chromium Use and Exposure Routes
Chromium is one of the top 10 most abundant minerals in Earth’s crust and
is most often encountered at one of its two most stable forms, trivalent [Cr(III)] or
hexavalent [Cr(VI)] (Jacobs & Testa, 2005). Naturally-occurring chromium is
largely in the form of Cr(III) and enters the environment through natural processes
such as volcanic eruption and erosion (Tchounwou et al., 2012). Cr(VI) is mostly
man-made and used for industrial purposes. Due to the unique chemical and
physical properties of Cr(VI) compounds, discontinuation of their use or
replacement is challenging, if not impossible. The volume of production and use of
Cr(VI) continues to increase and consequently, waste, by-products, and leaching
from commercial products cause Cr(VI) to become ubiquitous in the environment.
The human health risks of Cr(VI) was first studied in chromate workers (Langård
and Vigander, 1983; Lindberg and Hedenstierna, 1983; Moller et al., 1986;
Ishikawa et al., 1994). Evaluation of health impacts related to environmental levels
of Cr(VI) contamination are still in need of investigation.
Chromate compounds provide resistance to corrosion and fouling and
produce salts of bright colors. They have broad industrial usage including in
pigment production, paints, anti-corrosives, leather tanning, wood preservatives,
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cement mixtures, electroplating, stainless steel welding, and metal processing.
Contamination arises from manufacturing wastes, mining waste, toxic dust, and
degradation of paints and coatings (Jacobs & Testa, 2005; NIOSH, 2013). In
addition to primary chromate use, Cr(VI) is released as a by-product from waste
incineration, diesel fuel and coal combustion, and cooling towers (Kingston et al.,
2005; Wang et al., 2003; Astrup et al., 2005; Parr et al., 1976).
Exposure can occur through inhalation, dermal contact, or ingestion of
contaminated water or soil. Carcinogenicity by oral exposure is controversial.
Some have suggested high rates of reduction to Cr(III) in saliva and stomach acid
should reduce absorption of Cr(VI) (Proctor et al., 2002; Paustenbach et al., 2003).
Indeed, some studies have shown lower rates of Cr absorption and DNA damage
biomarkers after oral exposure (De Flora et al., 2008; Kuykendall et al., 1996;
Costa, 1997). However, these results may be due to the timeframe of the studies,
as prolonged exposure to animals caused hyperplasia and metaplasia of stomach
and small intestine (Bucher, 2007) and human populations exposed to
contaminated water had high rates of cancer deaths (Linos et al., 2011; Beaumont
et al., 2008). Dermal exposure is known to cause allergic contact dermatitis, but
serious injury by this route is rare (Lin et al., 2009; Paustenbach et al., 2003). Cr(VI)
primarily targets the respiratory system. Over 1.3 million workers are reportedly
exposed to airborne Cr(VI) in Europe and the United States alone (NIOSH, 2013;
IARC, 2012). Many countries do not have adequate reporting to estimate worker
risks and do not regulate occupational exposure as in the United States and
Europe. Additional to occupation risks, in the United States, industrial sources
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release up to 2,900 tons of chromium into the atmosphere (ATSDR, 2012), and
total global atmospheric emission is estimated at 58,000 to 112,000 tons per year
(Johnson et al., 2006). Approximately one third of these emissions are in the
hexavalent state (Johnson et al., 2006). Thus, potential Cr(VI) exposure is a
concern for anyone living near an industrial area, and effects of low, chronic levels
of airborne-Cr(VI) are relatively unknown.

Physical and Chemical Properties of Chromium
Chromium exists in valence states from chromium (0) to chromium (VI).
Cr(0), Cr(III), and Cr(VI) are environmentally stable. Cr(0) is metallic chrome, used
for making steel. Cr(III) and Cr(VI) form brightly colored salts of variable solubilities.
The reason human health risks center around Cr(VI) exposure and not Cr(III) is
due to chemical and toxicokinetic differences of the valence states. Cr(III) readily
binds to extracellular molecules and evidence suggests this hinders its entry into
cells (Wetterhahn and Hamilton, 1989; Cohen et al., 1993). However, due to
structural mimicry of phosphate and sulfate, Cr(VI) enters cells via facilitated
diffusion through anion channels (Jennette, 1981). Gao et al. (1993) measured Cr
distribution in various rat tissues after intratracheal instillation and found elevated
Cr levels in whole blood, plasma, and urine after Cr(VI) but not Cr(III) treatment,
lending evidence to lower absorption of Cr(III) compared to Cr(VI). The Cr(VI)
anion specifically generated outside of the cell has been shown to be responsible
for clastogenesis. Cr(VI) particles can be phagocytosed by cells, but particle
internalization without extracellular dissolution does not contribute to clastogenesis
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(Xie et al., 2004). Also, after extracellular dissolution, the cation of the chromate
salt can enter the cell, but it has no apparent contribution to the carcinogenic effect
of the Cr(VI) compound (Wise et al., 2004).
Chromium is proposed to damage cells by two approaches. First, inside the
cell, Cr(VI) is rapidly reduced to Cr(III) by agents such as ascorbate and
glutathione, producing chromium intermediate species and reactive oxygen
species that can damage intracellular molecules (Standeven and Wetterhahn,
1989; Suzuki, 1990; Hu et al., 2016). Secondly, the ability of Cr(III) to bind to
proteins and guanine bases raises the possibility for direct interactions to damage
molecular targets (Brown et al., 2020; Hneihen et al., 1993; Peterson et al., 2008).
Bound Cr(III) is unable to leave the cell or penetrate the plasma membrane (OSHA,
2006). Intracellular depletion of Cr(VI) by reduction favors Cr(VI) diffusion into the
cell. Chromium-biomolecule complexes have been implicated in protein
interference as well as severe DNA damage.
Cr(VI) compounds vary in solubility which influences their carcinogenic
potential. Fully soluble chromates such as sodium chromate and potassium
chromate are relatively less carcinogenic than water-insoluble chromates such as
lead chromate and barium chromate (Bragt and van Dura, 1983; Levy et al., 1986).
Differences in toxicity seem to correlate to the residence time and elimination time
of the various compounds. Insoluble Cr(VI) particles lodge at bronchial bifurcation
sites where they persist and release ions over a long period of time (ATSDR, 2012;
OSHA, 2006). The efficiency of particle elimination by the mucociliary clearance
mechanism depends on the size of the particle, location of deposition, and the
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health of the individual (OSHA, 2006). Bragt and van Dura (1983) tested a range
of soluble and insoluble chromates by intratracheal instillation in rats. They found
soluble compounds are absorbed more quickly and thus soluble chromate levels
in the lung decrease more rapidly than particulate chromates. They also concluded
slightly soluble compounds such as zinc chromate were more potent than soluble
sodium chromate or insoluble lead chromate. Compounds classified as “slightly
soluble” possess the particulate nature that incurs long residence times in the lung,
but increased solubility that causes greater local ion concentrations than highly
insoluble particulates. Cell culture studies also showed insoluble Cr(VI) is more
potent than soluble chromates (Patierno et al., 1989; Wise et al., 2006).

Chromium Carcinogenesis
Cr(VI) is a category 1 carcinogen recognized by the IARC, meaning
sufficient evidence concludes that it is carcinogenic to humans. It is listed among
the top 20 on the Agency for Toxic Substances and Disease Registry (ATSDR)
Substance Priority List, which prioritizes substances based not only on their
toxicity, but on their abundance and risk of human exposure (ATSDR, 2020). In
2006, the Occupational Safety and Health Administration (OSHA) recognized the
dangers of Cr(VI) and reduced occupational exposure limits to 5 µg/m3 of air
(OSHA, 2006).
Cr(VI)

is

a

potent

carcinogen,

as

demonstrated

by

numerous

epidemiological, animal, and cell culture studies. High rates of lung cancer have
been observed in chromate pigment workers since the 1930s (Machle and
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Gregorius, 1948; Baetjer, 1950). Follow-up studies of workers employed at a
Norwegian zinc chromate pigment plant between 1948 and 1972 show that 6 of 24
workers employed over 3 years, and 6 of 18 workers exposed for over 5 years
developed bronchial carcinomas in excess of the expected local rates (Langård &
Vigander, 1983). Intrabronchial pellet implantation of hexavalent chromates in rat
lungs produced bronchial carcinomas and demonstrated the carcinogenic potential
of several species of Cr(VI) (Levy et al., 1986). Cell culture studies show that Cr(VI)
causes DNA breaks, suppresses DNA repair, and contributes to aneuploidy (Xie
et al., 2005; Holmes et al., 2006; Wise and Wise, 2012; Browning et al., 2016).
Particulate Cr(VI) caused loss of contact inhibition and anchorage-independent
growth in human lung fibroblasts (Xie et al., 2008) and human lung epithelial cells
(Xie et al., 2007).

Cr(VI)-Induced Chromosome Instability
A major theory of Cr(VI) carcinogenesis is chromosome instability (CIN)
This theory is based on evidence that low rates of common oncogene mutations
are found in Cr(VI)-induced lung tumors, yet CIN is a common and early effect of
Cr(VI) exposure (Hirose et al., 2002; Kondo et al., 1997; Holmes et al., 2008;
Proctor et al., 2014; Wise et al., 2018; Wise et al., 2010). CIN has two main
categories: 1) structural CIN, featuring chromosome breaks and translocations,
and 2) numerical instability characterized by the loss or gain of entire
chromosomes (Funk et al., 2016; Palumbo and Russo, 2016; Negrini et al., 2010).
CIN entails a dynamic process manifesting as a changing karyotype (Duesberg et

6

al., 1998). The outcome of CIN can be measured as alterations in chromosome
structure or copy number, representing snapshots in time that evidence the
process of CIN. Structural or numerical aberrations alone are not synonymous with
CIN (Valind et al., 2013). For example, the immortalized human bronchial epithelial
cell line, BEP2D, features stable monosomy of chromosomes 12 and 13 and a
stable marker chromosome of the translocation of 12q and 13q (Willey et al., 1991,
Weaver et al., 1997). Such a stable translocation does not constitute structural
CIN. Similarly, in the condition of Down Syndrome stable trisomy 21 causes an
aneuploid karyotype of 47 chromosomes but does not cause dynamic missegregation of chromosomes as in numerical CIN (Valind et al., 2013, Schukken
and Fiojer, 2018). In this dissertation, we will use the term aneuploidy to refer to a
singular measurement of non-diploid chromosome number, and the term
numerical CIN refers to fluctuating chromosome numbers.
It is unknown precisely how Cr(VI) causes CIN, but it is an early event after
Cr(VI) exposure, and a hallmark of cancer (Holmes et al., 2006; Wise et al., 2010;
Hanahan and Weinberg, 2011). Cr(VI) causes DNA strand breaks, chromosome
breaks, gaps, and translocations, measured by single-cell gel electrophoresis,
chromosome aberration assay, and gamma-H2Ax immunofluorescence (Wise et
al., 2002; Xie et al., 2005; Wise et al., 2006; Xie et al., 2009; Ha et al., 2004).
Mechanisms of DNA damage are not entirely understood. Cr(VI)-induced
structural chromosome damage has been linked to formation of DNA lesions,
abasic sites, potential replication fork stalling, and loss of DNA repair mechanisms
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(Slade et al., 2005; Messer et al., 2006; Ha et al., 2004, Browning et al., 2016;
Browning et al., 2017).
How numerical instability arises is not fully understood but it is known that
mitotic disruption can cause asymmetrical segregation of chromosomes, resulting
in aneuploid daughter cells. Numerical CIN is the most common form of CIN in
cancer (Vasudevan et al., 2021; Brinkley, 2001). While aneuploidy can confer loss
of fitness, the dynamic nature of CIN allows genetic variation within cell populations
from which cancer hallmarks can emerge (Stingele et al., 2012; Duijf and Benezra,
2013). Gain or loss of chromosomes causes gene imbalances that perturb
pathways critical to genomic stability, such as DNA repair, cell cycle regulation,
and DNA segregation (Vasudevan et al., 2021; Pavelka et al., 2010; Stingele et
al., 2012; Duijf and Benezra, 2013). Rate of tumor progression is influenced by
dramatic shifts in ratios of tumor suppressor genes or oncogenes incurred by
chromosome gains and losses (Fukasawa, 2005).

Centrosome Amplification Drives Numerical Chromosome Instability
Aneuploidy is usually caused by chromosome segregation errors, which
result from failure of cytokinesis, or from mitotic disruptions such as loss of
checkpoint control, kinetochore attachment errors, and centrosome amplification
(Fukasawa, 2005). Centrosome amplification in this study is defined as a single
cell having more than two centrosomes. Centrosome amplification has not been
investigated in tumors caused by Cr(VI), but it is observed in most solid and
hematological cancers (Chan, 2011). Cell culture studies show Cr(VI)-induced
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centrosome amplification is the likely driver of numerical CIN (Holmes et al., 2006;
Holmes et al., 2010; Bian et al., 2022). Aberrant mitosis and centrosome
amplification correlate with Cr(VI)-induced numerical CIN in human lung fibroblasts
(Holmes et al., 2006; Martino et al., 2015). Cr(VI)-transformed BEP2D cells,
identified by loss of contact inhibition and gain of anchorage-independent growth,
exhibited numerical CIN as well as centrosome amplification (Xie et al., 2007).
Other known metal carcinogens such as arsenic, and cadmium also induce
centrosome amplification and numerical CIN (Wise & Wise, 2010; Zhang et al.,
2019; Ochi, 2002; Yih et al., 2006). Thus, numerical CIN is a key event in Cr(VI)
carcinogenesis, and metal carcinogenesis in general, and centrosome
amplification should be investigated further as a mechanism for its induction.

Centrosomes in Carcinogenesis
Cr(VI) causes numerical chromosome instability, likely through its ability to
induce centrosome amplification. How Cr(VI) causes centrosome disruption is
unknown and is the focus of this dissertation. Previous work shows Cr(VI) causes
premature centriole disengagement which is known to cause centrosome
overduplication (Martino et al., 2015; Tsou and Stearns, 2006a,b). Centrosomes
are a relatively recent focus of Cr(VI) research. Only four studies address
centrosome-specific effects of Cr(VI) (Holmes et al., 2006; Holmes et al., 2010;
Martino et al., 2015; Bian et al., 2022). To fill knowledge gaps in the molecular
mechanisms of Cr(VI)-induced centrosome disruption this study focuses on
regulators of centriole engagement, and most intensely the protein securin, to
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uncover the source of centrosome amplification. Background on centrosome
structure and function is presented here, along with relevant findings in Cr(VI)
research.
Centrosomes have been implicated in cancer for decades. In 1902, Theodor
Boveri published a theory of cancer, including "the suggestion that malignant
tumors might be the result of a certain abnormal condition of the chromosomes,
which may arise from multipolar mitosis," and became the father of the
chromosome theory of cancer and the first to implicate centrosomes in
carcinogenesis (McKusick, 1985). Since then, other authors have supported the
theory that centrosome amplification is central to chromosome instability in cancer
(Lingle et al., 2002; Sato et al., 2001; Skyldberg et al., 2001). Centrosome
amplification is observed in the majority of solid and hematological cancers and is
associated with late-stage tumors, early neoplasia, and is an early effect in cell
culture studies (Chan, 2011; Nigg et al., 2002), indicating its role in both initiation
and progression of cancer. In breast cancers, 60-80% of tumors have centrosome
amplification and Lingle et al. (2001) found in situ ductal carcinomas showed
centrosome numbers correlating with aneuploidy and chromosome instability.
Levine et al. (2017) reported in vivo induction of supernumerary centrosomes was
sufficient to cause mammary tumors in mice.
The centrosome is the microtubule organizing center of the cell. It functions
to nucleate microtubules and plays roles in cell processes such as ciliogenesis,
cell motility, cell signaling, Golgi organization and mitotic spindle formation
(Bettencourt-Dias and Glover, 2007; Rios, 2014; Bornens, 2002). The mature
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centrosome is a membrane-free organelle composed of two centrioles surrounded
by a protein cloud known as the pericentriolar material (Moritz et al., 1995). The
centrioles are cylindrical tubes formed of nine triplet stacks of microtubules. They
are approximately 0.5 um in length and 0.2 um wide (Agircan et al., 2014). The
pericentriolar material contains multiple associated proteins, including gammatubulin that acts as the nucleation seed for microtubule generation. We used
gamma-tubulin as a marker to visualize and count centrosomes. While the
pericentriolar material imparts functionality to the centrosomes, the centrioles
determine the replication status of the centrosome (Agircan et al., 2014). The
structure of the centrosome is illustrated in Figure 1.
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Figure 1. Centrosome structure. The mature centrosome is composed of two
centrioles engaged in perpendicular arrangement. The centrioles are embedded
in the pericentriolar material, a protein matrix including gamma-tubulin. The
centrioles are supported in engagement by cohesin rings and kendrin protein. The
distal lumen of the centrioles contain centrin and C-Nap1 is localized to the
proximal ends.
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The focus on centrosomes in cancer lies in their powerful influence over
chromosome segregation. In culture, multipolar cells featuring more than two
centrosomes are observed to segregate chromosomes asymmetrically or into
more than two daughter cells (Ochi, 2016; Weaver et al., 2007). For the most part,
severe asymmetry and multicellular cytokinesis are fatal to the daughter cells
(Weaver et al., 2007). However, centrosome amplification can be tolerated by
clustering or inactivating supernumerary centrosomes (Brinkley, 2001; Vitre et al.,
2020). While clustering aids cell survival by promoting bipolar spindle formation, it
does not guarantee against aneuploid daughter cells. Clustered centrosomes can
block one another to interfere with proper microtubule-kinetochore attachment so
that bipolar division with supernumerary centrosomes causes asymmetrical
chromosome division (Ganen et al., 2009; Silkworth et al., 2009).
Centrosome amplification can occur by various avenues. Failure of
cytokinesis results in cells that have a 4N complement of DNA and inherit two
centrosomes instead of one per cell (Normand and King, 2010). These
centrosomes can then duplicate during S phase, giving the cell four mature
centrosomes (Fukasawa, 2005). De novo centrosome amplification occurs when
centriolar synthesis-associated proteins are overexpressed and form centrosomes
independently of mother centrioles (Godinho & Pellman, 2014; Tsou & Stearns,
2006a). Another scenario involves the fragmentation of the pericentriolar material
which then is able to function as an acentriolar centrosome (Fukasawa, 2005).
Cr(VI)-exposed cells do not show a large number of acentriolar centrosomes and
amplification occurs in cells with diploid DNA content, indicating that cytokinesis
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failure is not a prominent source of centrosome amplification (Holmes et al., 2010).
The most likely mechanism for Cr(VI)-induced centrosome amplification is
premature reduplication during interphase. Evidence points to premature
disengagement and loss of reduplication blocks as key steps in Cr(VI)-induced
centrosome amplification (Martino et al., 2015).
Normally, in late mitosis or early G1, the centriole pair disengages.
Disengagement is the licensing step for duplication (Tsou & Stearns, 2006a,b).
Engagement blocks the recruitment of proteins involved in centriolar synthesis,
including Plk4, SAS6, Cep135, and STIL, required to form the daughter centriole
cartwheel on the side of the mother centriole (Conduit et al., 2015; Nigg & Stearns,
2011; Wang et al., 2014). Disengagement is caused by cleavage of the centriole
linkers, kendrin and cohesin, by the enzyme, separase (Nakamura et al., 2009;
Karki et al., 2017; Matsuo et al., 2012). Securin is the regulator of separase and
thus key in controlling the timing of centriole disengagement (Lee and Rhee, 2012).
Centriole disengagement by separase is illustrated in Figure 2. Centrosome
overduplication along with centriole disengagement has been shown to occur
during extended G2 arrest in the presence of DNA damaging agents (Dodson et
al., 2004; Douthwright & Sluder, 2014; Inanc et al., 2010; Karki et al., 2017).
Martino et al. reported significant premature centriole disengagement after
exposure of human lung cells to zinc chromate (Martino et al., 2015). Increase in
centriole disengagement followed a similar pattern over time and treatment
concentrations as centrosome amplification in those cells, supporting the theory of
centriole disengagement as a key process in Cr(VI)-induced centrosome
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amplification (Martino et al., 2015). Yet, it is unknown how centriole engagement
becomes dysregulated by Cr(VI). Current knowledge points to the integrity of
kendrin and cohesin and the timing of separase activity as critical points of
regulation. In this dissertation, we focus on securin, separase, and their influence
on centriole linkers as potential targets of Cr(VI) exposure.
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Se
cu
rin

Separase
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Figure 2. Centriole disengagement is caused by separase activity. Securin inhibits
separase. When securin is degraded, separase is released and its enzyme activity
cleaves centriole linkers, securin and kendrin, to cause centriole disengagement.
Centriole disengagement licenses centrosome duplication.
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Securin and Separase
Separase is a large cysteine protease with roles in chromosome
segregation, DNA repair, centriole disengagement and centrosome duplication
(Baum et al., 1988; Uhlmann et al., 1999; Nagao et al., 2004; Hellmuth et al., 2018;
Tsou et al., 2009; Lee et al., 2012). Human separase is approximately 233 kDa
(UniProt.org, 2010). It has a catalytic domain at the C-terminal end that is highly
conserved among eukaryotes, an unstructured middle hinge region, and a helical
N-terminal region which varies with species (Luo and Tong, 2021; Viadiu et al.,
2005). Separase is largely localized in the cytoplasm in normal, undamaged cells
(Sun et al., 2006). It is excluded from the nucleus both by virtue of its large size
and by a nuclear export signal on its C-terminal end that ensures the catalytic
activity is not present in interphase cells (Sun et al., 2006). The catalytic domain is
responsible for endopeptidase activity causing cleavage of its substrate proteins
at conserved recognition sites (Sullivan, et al., 2004; Waizenegger et al., 2000;
Hauf et al., 2001; Waizenegger et al., 2002). The substrates of separase relevant
to this project are separase, kendrin, and the SCC1 subunit of cohesin (Matsuo et
al., 2012; Rosen et al., 2019; Waizenegger et al., 2002).
Separase cleaves proteins after an arginine (R) residue in the motif E-X-XR, in which X is any amino acid (Waizenegger et al., 2000; Hauf et al., 2001;
Waizenegger et al., 2002). Separase contains three cleavage sequences that
serve as substrates of its own catalytic site and upon activation separase can
cleave itself (Waizenegger et al., 2002). Though the cleavage status does not alter
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enzyme function (Waizenegger et al., 2002), it is used as a marker of separase
activity.
Kendrin is a huge, 378 kDa coiled-coil protein that localizes in the
pericentriolar region of centrosomes to support and protect centriole engagement
(Doxsey et al., 1994; Matsuo et al., 2012). Kendrin, also named pericentrin,
contains a separase cleavage sequence at R2231 which if mutated causes kendrin
to escape separase cleavage and prevents centriole disengagement (Matsuo et
al., 2012). Separase activity is distinctly controlled at the centrosome to cause
kendrin

cleavage

(Agircan

and

Schiebel,

2014)

and

allow

centriole

disengagement.
Separase is responsible for cleaving the cohesin ring, which holds the
centromeres of sister chromatids together. The cohesin ring is a complex
composed of subunits SMC1, SMC3, SCC1/RAD21, and SA1 or SA2, depending
on the isoform (Losada et al., 2000; Sumara et al., 2000; Sumara et al., 2002).
Most cohesin rings are located along the arms of chromosomes and are released
in prophase by a separase-independent mechanism (Losada et al, 2000; Losada
et al., 2001; Kueng et al., 2006). However, cohesin at the centromeres is protected
by the protein shugoshin (Watanabe and Kitajima, 2005) and only released upon
separase activity (Hauf et al., 2001). SCC1, also named RAD21, is the cohesin
subunit cleaved by separase (Uhlmann et al., 1999; Waizenegger et al., 2000).
Cleavage of SCC1 opens the cohesin ring (Uhlmann et al., 1999). Cleavage of
centromeric cohesin allows separation of chromatids into daughter cells during
mitosis, and this function of separase is critical for progression through anaphase
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and cytokinesis (Hauf et al., 2001; Funabiki et al., 1996; Ciosk et al., 1998).
Cohesin is present also at the centrosomes where it helps hold centriole pairs in
engagement. Separase activity reporters show cohesin cleavage at centrosomes
occurs before cohesin cleavage at the centromeres, indicating location-specific
timing of separase activity (Agircan and Schiebel, 2014).
Separase regulation is critical to control the timing of its cleavage activity.
Multiple control mechanisms exist, including inhibitory binding by securin and the
cyclin B1-cdk1 complex and inhibitory phosphorylation (Huang et al., 2008; Yu et
al., 2021; Stemmann et al., 2001; Ciosk et al., 1998, Gorr et al., 2005). Securin is
the main inhibitor and binds to separase throughout the cell cycle (Ciosk et al.,
1998; Hornig et al., 2002). After the discovery of separase function, the yeast
securin homolog, Pds1, was found to be the regulator of separase activity, which
was released by degradation mediated by the anaphase-promoting complex
(APC) (Cohen-Fix et al., 1996). Vertebrate securin was discovered in 1999 and
found to be the same product of PTTG (pituitary tumor-transforming gene) and
thus linked to carcinogenesis via its effects on chromosome disjunction (Zhou et
al., 1999). Human securin is approximately 22 kDa and features a KEN-box region
and a D-box (destruction-box) region, both of which are required for anaphase
promoting complex/cyclosome (APC/C) recognition and degradation (Zur and
Brandeis, 2001). The pseudo-substrate region is where it interacts with separase.
The securin sequence varies among eukaryotes, but its function remains
conserved. Securin associates with nascent separase and acts as a chaperone
that enables its proper folding and solubility (Hornig et al., 2002). Securin binding
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to separase primes it for activity and securin absence depresses separase activity
(Hornig et al., 2002; Jallepalli et al., 2001; Mei et al., 2001). Securin occupies the
active site via its pseudo-substrate sequence and prevents cleavage activity until
it is ubiquitinated at anaphase by APC/C and subsequently degraded by the
proteasome (Cohen-Fix et al., 1996; Zhou et al., 1999; Zur and Brandeis, 2001;
Hagting et al., 2002).
Since securin is the main inhibitor of separase, and separase function is so
critical to chromosome stability, it is surprising that knockout mouse and human
cell studies show securin is not essential to the normal function of cells (Mei et al.,
2001; Jallepalli et al., 2001; Pfleghaar et al., 2005). Inhibitory phosphorylation
contributes to separase regulation (Stemmann et al., 2001; Gorr et al., 2005;
Helmuth et al., 2015) but is not sufficient alone for inhibition. Cyclin B1 can bind to
separase and inhibit its activity. Cdk1 partnered to cyclin B1 phosphorylates
separase, which causes it to aggregate and thus deactivate (Stemmann et al.,
2001; Gorr et al., 2005). Association of the cdk1-cyclin B1 complex with separase
keeps it soluble and ready to activate, similar to how securin maintains separase
in an inactive but ready state (Helmuth et al., 2015; Gorr et al., 2005). Cyclin B1 is
degraded by the APC/C pathway also at the anaphase transition, allowing it to
compensate for securin loss (Hellmuth et al., 2015).
It was first discovered in Saccharomyces cerevisiae that separase
deregulation leads to centrosome amplification, but this defect was prevented if
cells were held in G1 or G0 phase (Baum et al., 1988). Separase activity is
implicated in breast cancer, as it is a marker for tumor progression (Gurvits at al.,
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2017), and modification of separase can induce or suppress tumorigenic outcomes
in experimental animals and cells (Zhang and Pati, 2018; Zhang et al., 2018;
Mukherjee et al., 2014). In lung cancer, securin dysregulation is implicated in
promoting invasion and migration of non-small cell cancer cells (Li, et al, 2013). In
patients with acute myeloid leukemia (AML), the transition from myelodysplastic
syndrome to AML was correlated to separase activity and centrosome aberrations
(Ruppenthal et al., 2018).
In this summary, we highlight the carcinogenic implications of centrosome
amplification and specifically the regulatory proteins, securin and separase, and
centriole linkers, kendrin and cohesin. In our pursuit of molecular targets of Cr(VI),
we focus on these centriole-associated regulatory proteins. These key regulation
points are widely studied in cell biology research but are understudied in the field
of Cr(VI) carcinogenesis.

One Environmental Health Approach for Environmental Toxicology
The One Health philosophy proposes that the health of all living inhabitants
on earth is interconnected and insights from any human, animal, or ecosystem
health field can contribute to the enhancement of the others. The One
Environmental Health approach specifically focuses on the shared toxicants
relevant to human, animal, and ecosystem health (Pérez and Wise, 2018). This
approach extends the advancements made by the systems biology paradigm to
holistic consideration of multidisciplinary research scaling from molecules, cells,
and organisms to ecosystems (Zinsstag et al., 2011). In the context of this
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dissertation, we use a species comparison to tease apart the differences in
molecular responses to Cr(VI) and gain insights into key events in the carcinogenic
mechanism.
Cr(VI) is a global environmental contaminant and thus a relevant toxicant to
One Environmental Health studies. Cr(VI) can form naturally from oxidation
reactions with Cr(III) (Jacobs & Testa, 2005), but Cr(VI) in the environment largely
arises from industrial activities.
Geisler and Schmidt (1992) provided an overview of marine chromium.
They reported the thermodynamically stable valence state and the dominant
species of chromium in sea water is Cr(VI). Erosion and industrial runoff contribute
to chromium input into the ocean, but another large source is deposition from the
air, which indicates that both marine waters and atmosphere are contaminated
with Cr(VI) (Geisler and Schmidt, 1992; Jacobs & Testa, 2005; Tchounwou et al.,
2012). The range of chromium levels in sea water have been reported as 5 to 800
µg/L (Jacobs and Testa, 2005) and 2 to 5 nmol/kg (Geisler and Schmidt, 1992).
Environmental reduction of Cr(VI) to Cr(III) can occur under acid conditions, for
example in anoxic marine zones with hydrogen sulfide present (Geisler and
Schmidt, 1992).
Whales are of particular interest in environmental toxicology because they
are the closest marine relative to humans. Whales have long life spans, breathe
air, and are potentially exposed to Cr(VI) by skin, ingestion, and inhalation.
Chromium accumulates in whale skin and levels vary among geographically
diverse populations. Wise et al. (2009) analyzed sperm whale skin biopsies from
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361 individuals across 16 ocean regions (Wise et al., 2009). Chromium levels
ranged from 0.9 to 122.6 µg/g of tissue, with a global mean of 8.8 ± 0.9 µg/g, which
is 28-fold higher than the mean Cr levels in human skin without occupational
exposure. Regional means ranged from 3.3 ± 0.4 µg/g to 44.3 ± 4.4 µg/g. Fin whale
skin biopsies from the Gulf of Maine had mean Cr levels of 10.07 µg/g tissue (Wise
et al., 2015).
Interestingly, cell culture studies have shown that particulate Cr(VI) is less
genotoxic to whale cells than human cells (Browning et al., 2017; Li Chen et al.,
2012; Li Chen et al., 2009). Fewer instances of structural chromosome damage
occurred to North Atlantic right whale lung cells versus human lung fibroblasts
exposed to lead chromate (Li Chen et al., 2009). Lead chromate produced 3- to 5fold fewer damaged metaphases in sperm whale skin cells compared to human
skin cells (Li Chen et al., 2012). Thus, it appears that whales have protective
mechanisms against Cr(VI)-induced structural chromosome damage. This
dissertation investigates Cr(VI)-induced numerical chromosome instability in whale
cells. By comparing whale-specific cellular and molecular responses to those of
humans, we can further elucidate key mechanistic events of Cr(VI) carcinogenesis
and uncover how whales may resist cancer.

Summary and Dissertation Aims
Lung cancer is the leading cause of cancer deaths worldwide. While the
most familiar risk factor is cigarette smoking, up to 25% of cases occur in
individuals who never smoked (Samet et al., 2009, Sung et al., 2021; Couraud et
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al., 2012). Thus, understanding occupational and environmental carcinogens is
critical in the battle against lung cancer. Metals are a major cause of lung cancer.
Hexavalent chromium [Cr(VI)], which is both an occupational and environmental
contaminant, is a known carcinogen and among the top 20 on ATSDR’s Substance
Priority List (ATSDR, 2020). Lung tumors feature high incidences of aneuploidy
and centrosome amplification, and this phenotype has been reproduced by Cr(VI)
exposure in vitro (Holmes et al., 2006; Holmes et al., 2010; Martino et al., 2015).
Centrosome amplification is gaining recognition as not only a hallmark of many
cancers, but a potential key in carcinogenesis because it can lead to aneuploidy.
The goal of this dissertation is to identify the mechanism of Cr(VI)-induced
centrosome amplification. The central hypothesis of this project is: Cr(VI) causes
loss of the key centrosome regulator, securin, causing aberrant separase activity,
which leads to premature centriole disengagement, centrosome amplification, and
numerical chromosome instability. Figure 3 shows a graphical representation of
the hypothesis. I will examine the molecular changes that underlie this phenotype
in three aims.
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Figure 3. The central hypothesis of this project. Cr(VI) causes loss of the key
centrosome regulator, securin, causing aberrant separase activity, which leads to
premature centriole disengagement, centrosome amplification, and numerical
chromosome instability.
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Aim 1. Particulate Hexavalent Chromium-Induced Securin Disruption
Drives Numerical Chromosome Instability in Human Lung Cells. Aim 1
investigates the proteins involved in Cr(VI)-induced premature centriole
disengagement. Centriole disengagement is the licensing step to centrosome
duplication and untimely release of this blocking mechanism allows multiple rounds
of centriole synthesis (Tsou et al., 2006a; Tsou et al., 2006b). Centriole
disengagement has been observed by our lab after Cr(VI) exposure to normal
human lung cells (Holmes et al., 2006; Holmes et al., 2010; Martino et al., 2015)
and thus is a likely cause of centrosome amplification in Cr(VI)-exposed cells.
Separase cleaves cohesin and kendrin at the centrosomes, implicating it as a key
factor in centriole disengagement. Securin is the canonical separase inhibitor and
cyclin B1 is a secondary inhibitor. Thus, this project focuses on securin loss in
normal human lung fibroblasts, which could result in increased separase activity,
and addresses the role of cyclin B1 as a secondary inhibitor. We measure securin
protein levels, and address two possible avenues of securin loss, including
increased protein degradation and decreased securin messenger RNA (mRNA)
levels. We also measure cyclin B1 protein after Cr(VI) exposure. Next, we seek to
confirm the roles of securin and separase using siRNA-induced gene knockdown
to induce or rescue Cr(VI)-associated phenotypes.
Aim 2. Mechanisms of Hexavalent Chromium-Induced Securin
Disruption. We have seen that Cr(VI) causes a wide variety of protein alterations
in the cell and decreased protein levels will have cascading effects across several
pathways. Aim 2 dives deeper into how Cr(VI) alters securin protein expression. It
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is important to assess if securin transcription factor protein levels are also altered.
This Aim focuses on pre-transcriptional disruption by two avenues: 1) Loss of
transcription factors that promote securin transcription and 2) increased levels of
transcription factors that inhibit securin transcription.
This aim measures Cr(VI) effects on levels of three transcription factors that
bind to the securin promoter region and enhance transcription of the securin gene:
Sp1, NF-YA, and in certain cases E2F1. Binding of both Sp1 and NF-YA at the
securin promoter is required for securin transcription (Clem et al., 2003).
Therefore, if Cr(VI) alters either of these proteins, securin expression would be
hindered. We have shown E2F1 is targeted by Cr(VI) (Speer at al., 2021) and will
investigate E2F1 as a possible mechanism for securin expression loss. Cr(VI)
exposure not only changes protein levels, but can also alter protein localization
(Speer at al., 2021) and so we also measure transcription factor levels in nuclear
and cytoplasmic fractions to determine if nuclear function may be maintained after
Cr(VI) exposure. In addition to transcription factors that promote securin
transcription, we also investigate transcription factors that are known to have an
inhibitory effect, namely KLF6 and p53 (Lee at al., 2010; Chen et al., 2013; Zhou
et al., 2003). We measure alteration in protein levels and localization after Cr(VI)
exposure.
In the pursuit of the mechanism by which Cr(VI) induces loss of securin
mRNA, we also investigate potential effects of microRNA (miRNA) regulation.
MiRNAs are increasingly recognized for their potential roles in environmental
carcinogenesis (Wu et al., 2019; Pratap et al., 2018; Gonzalez et al., 2015; Li et
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al., 2014). MicroRNA sequencing shows Cr(VI) causes global miRNA
dysregulation. Speer et al. (2022) found miRNAs were significantly affected in all
tested timepoints and concentrations, including up- and down-regulation of
multiple miRNAs involved in several cancer pathways. We analyzed the miRNAs
that are significantly altered by Cr(VI), to identify potential targets in the pathways
of securin and other centrosome regulators.
Aim 3. Whale Cells Resist Hexavalent Chromium-Induced Securin
Disruption. In Aim 3 we undertake the first study of centrosome amplification in
whale cells. Whales are long-lived mammals that are exposed to significant levels
of environmental chromium. We show whale cells are resistant to Cr(VI)-induced
securin loss, centrosome amplification, and numerical chromosome instability.
Comparative data from whales yield supportive evidence for key mechanisms of
centrosome amplification and provide insights into molecular strategies against
metal-induced carcinogenesis.
Figure 4 shows an overview of the project, including the mechanism of
particulate Cr(VI) dissolution and uptake and the hypothesis of this project.
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Figure 4. Overview of Cr(VI) uptake and proposed mechanism of carcinogenesis.
Cr(VI) particles can be phagocytosed, but have no apparent contribution to Cr(VI)
carcinogenesis. Particulate Cr(VI) dissociates outside the cell into the chromate
anion and the cation. The cation can enter the cell via calcium channels, but has
no apparent contribution to Cr(VI) carcinogenesis. The Cr(VI) anion enters the cell
membrane via anion transport channels. Inside the cell Cr(VI) is reduced to Cr(V),
Cr(IV), and Cr(III) and the reduction process generates reactive oxygen species.
We propose one or more of these products induces securin protein loss, which
causes aberrant separase activity, leading to premature centriole disengagement.
Centriole disengagement causes centrosome amplification, which drives
numerical CIN which causes neoplastic transformation and ultimately leads to
cancer.
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CHAPTER 2: METHODS AND MATERIALS

Chemicals and Reagents
DMEM and Ham’s F-12 (DMEM/F-12) 50:50 media, glutagro 200 mM Lalanyl-L-glutamine supplement, sodium pyruvate, and Dulbecco’s phosphatebuffered saline (DPBS), tissue culture flasks, dishes and plasticware were
purchased from Corning, Inc. (Manassas, VA). Cosmic calf serum and
penicillin/streptomycin was purchased from HyClone (Logan, UT). Sodium
pyruvate (100 mM) and MycoAlert kit were purchased from Lonza (Allendale, NJ).
Trypsin-EDTA (0.25%) and KaryoMAX® Colcemid Solution (10 µg/ml) was
purchased from Gibco. Zinc chromate (CAS# 13530-65-9, 99.7% purity) was
purchased from Pfaltz and Bauer (lot Z00277, Waterbury, CT). HALT protease and
phosphatase inhibitor cocktail, RIPA buffer, NE-PER nuclear and cytoplasmic
extraction reagents, mirVana miRNA isolation kit, High Capacity cDNA Reverse
Transcription, TaqMan Assays, glass chamber slides, Super Up Rite slides were
purchased from Thermo Fisher Scientific Inc. (Waltham, MA). Dharmacon ONTARGET siRNAs (siESPL1, siPTTG1, siCCNB1, siE2F1, siNF-YA, siSp1, and
non-targeting siRNA), DharmaFECT transfection reagent, and 5X siRNA buffer
were purchased from Horizon Discovery (St. Louis, MO). Mini-Protean TGX gels,
4X protein sample loading buffer, Odyssey blocking buffer (TBS), IRDye® 800CW
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and IRDye® 680RD near-infrared fluorescent secondary antibodies were
purchased from Li-Cor (Lincoln, NE). FNC Coating Mix® (fibronectin, collagen,
albumin mix) was purchased from Athena Environmental Sciences, Inc.
(Baltimore, MD). Tween-20, cycloheximide (CHX), methanol, sodium dodecyl
sulfate (SDS), potassium chloride, nitric acid and micro cover glass were
purchased from VWR International (Radnor, PA). Acetic acid was purchased from
Avantor

(Center

Valley,

PA).

Gurr’s

buffer

and

0.25%

trypsin-

ethylenediaminetetraacetic acid (EDTA) were purchased from Life Technologies
Corporation (Grand Island, NY). Giemsa stain was purchased from Ricca
Chemical Company (Arlington, TX). Ethylene glycol tetraacetic acid (EGTA), fish
skin gelatin, neocarzinostatin (NCS), and glycerol were purchased from SigmaAldrich, Inc. (St. Louis, MO). Normal goat serum was purchased from Abcam
(Eugene, OR). Piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) was purchased
from Alfa Aesar (Ward Hill, MA). Magnesium sulfate was purchased from J.T.
Baker (Phillipsburg, NJ). Bovine serum albumin was purchased from EMD
Millipore Corporation (Billerica, MA). Sodium azide was purchased from Amresco,
Inc. (Solon, OH). Prolong Diamond Antifade Reagent with DAPI and Alexa Fluor
secondary antibodies were purchased from Invitrogen (Eugene, OR). Anti-centrin
rabbit monoclonal antibody and anti-alpha-tubulin mouse antibody with FITC
conjugation were purchased from EMD Millipore Corporation (Temecula, CA).
Anti-CNAP1 (CEP250) rabbit polyclonal antibody was purchased from Proteintech
(Rosemont, IL). DyLight secondary antibodies were purchased from Jackson
ImmunoResearch (West Grove, PA). Anti-separase and anti-gamma-tubulin
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monoclonal mouse antibodies were purchased from Abcam (Eugene, OR). Antisecurin rabbit monoclonal, anti-alpha-tubulin mouse monoclonal, anti-cyclin B1
rabbit polyclonal, anti-p53 (phospho-Ser 15) rabbit, and anti-Sp1 rabbit polyclonal
antibodies were purchased from Cell Signaling Technology (Danvers, MA). Antip53 mouse monoclonal antibody was purchased from BD Biosciences (Franklin
Lakes, NJ). Anti-alpha-tubulin and anti-GAPDH mouse monoclonal antibodies
were purchased from GeneTex (Irvine, CA). Kendrin/pericentrin rabbit antibody
was purchased from Bethyl Laboratories (Montgomery, TX). Anti-NF-YA Rabbit
polyclonal antibody, anti-lamin B1mouse monoclonal antibody were purchased
from Invitrogen/Thermo Fisher (Rockford, IL). Anti-KLF6 mouse monoclonal
antibody was purchased from Santa Cruz Biotechnology (Dallas, TX). Anti-Scc1
monoclonal guinea pig antibody was a gift from Dr. Olaf Stemmann (University of
Bayreuth, Germany).

Human Cell Culture
The human lung cell line used was WTHBF-6 cells, a bronchial fibroblast
cell line developed from normal primary human bronchial fibroblasts, as previously
published (Wise et al., 2004). This clonal cell line has an hTERT-extended lifespan
with a normal, stable karyotype and displays the same growth rate and cytotoxic
and clastogenic response to metals as the primary parent cells (Wise et al., 2004).
Using this immortalized cell line enables consistent cell passaging and prolonged
exposure periods used in our toxicological assays. Fibroblast cell lines are relevant
cell models for Cr(VI)-induced lung cancer due to observations that chromium
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deposits in the bronchial stroma of chromate workers, but not in the epithelium
(Kondo et al., 2003). Human fibroblast cells are typically employed in toxicological
assays concerning aneuploidy given that currently available epithelial cell lines
demonstrate high background aneuploidy. Our study focuses on chromosomal
stability and thus a stable control karyotype is an important prerequisite.
WTHBF-6 cells were maintained according to our published methods (Wise
et al., 2004) as an adherent, sub-confluent layer in DMEM/F-12 media,
supplemented with 15% cosmic calf serum, 0.2 mM L-alanyl-L-glutamine, 100
IU/ml penicillin, 100 mg/ml streptomycin and 0.1 mM sodium pyruvate. Cells were
maintained in a humidified incubator at 37º C, 5% CO2. Cells were authenticated
through karyotyping when thawed for use and after every 3 months of continuous
culture. Short tandem repeat analysis was conducted approximately yearly to
confirm authenticity. Monthly mycoplasma screening was performed and cells
were monitored for any growth or morphological changes during maintenance.

Whale Cell Culture
Primary whale cell lines developed from two whale species were employed in
our studies. SPW457sk is a primary skin fibroblast cell line derived from a female
sperm whale. Skin biopsy was obtained from a free ranging, healthy adult in the
Gulf of Mexico. BHW200Lu and BHW24Lu are a primary bowhead whale lung
fibroblast cell lines derived from two male whales obtained during subsistence
hunts in Barrow, Alaska. Whale fibroblasts were isolated from tissue and
maintained according to our published methods (Wise et al., 2011). Tissue was
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immersed

for

at

least

30

minutes

in

tissue

buffer

containing

2%

penicillin/streptomycin and 0.4% gentamicin. Tissue was sliced into small pieces
using sterile scalpel and placed in tissue culture flasks with 500 ml of L-15 media
containing 2% penicillin/streptomycin and 0.4% gentamicin. Flasks were incubated
at 33º C. After 48 hours, flasks were flooded with media and monitored for
fibroblast migration from explants. After colonization of the tissue culture flask,
tissue was removed and cell were released with 0.25% trypsin. Cell lines were
maintained at 33º C in a humidified chamber with 5% CO2. Adherent, sub-confluent
cells were maintained in DMEM/F-12 media, supplemented with 15% cosmic calf
serum, 0.2 mM L-alanyl-L-glutamine, 100 IU/ml penicillin, 100 mg/ml streptomycin
and 0.1 mM sodium pyruvate. Cells were frozen in growth media plus 10% DMSO
for long-term storage at -140º C.

Preparation of Zinc Chromate and Cell Treatments
All experiments are performed on logarithmically growing cells. WTHBF-6
cells have a doubling time of approximately 24 h (Wise et al., 2004) and were
allowed 48 hours after seeding to enter logarithmic growth phase before beginning
treatments. Whale cells have an approximate doubling time of 36 h (Wise at al.,
2011) and were allowed 72 hours to enter logarithmic growth phase before
experiment start time. According to published methods (Xie et al, 2009), zinc
chromate was prepared by washing twice with deionized H2O to remove water
soluble contaminants, rinsed twice with acetone to remove organic contaminants,
and thoroughly dried. Washed zinc chromate was suspended in sterile water and
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stirred overnight at 4ºC. Before treatment, fresh media was added to cell dishes
and zinc chromate suspension was applied at a concentration of 0, 0.1, 0.2, 0.3,
or 0.4 µg/cm2, as specified for experiment and cell type. Treatment durations were
24 and 120 hours. Cells were maintained during treatment period at 5% CO2 in a
humidified incubator. Human cells were maintained at 37º C and whale cells were
maintained at 33º C.

Clonogenic Survival Assay
Clonogenic survival assay was performed as previously published (Wise et
al., 1992) to measure cytotoxicity. This assay determines relative plating efficiency
of treated cells compared to untreated cells. Cell viability assays based on enzyme
or metabolic activities are unsuitable because Cr(VI) treatments can alter these
markers independent of cell survival. The clonogenic survival assay is wellestablished in the literature for Cr(VI) toxicity and is useful for evaluating optimal
chemical exposure levels and cell seeding density that enable prolonged
toxicological exposures. Cells were seeded on 6-well plates and treated as
described above. At the end of the treatment period, media were removed and
cells were rinsed with 1X DPBS and released from the plate with 0.25% trypsinEDTA. From each treatment condition, 2000 cells were seeded onto each of four
100 mm tissue culture dishes. Cells were maintained in culture, without any further
treatment, and media were changed every 5 days until colonies formed. Colonies
were stained with crystal violet. Colonies were counted in each dish and averaged
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across all dishes for each treatment. Average colony growth per treatment group
are reported relative to the control group. Three experiments were performed.

Chromosome Instability Analysis
Chromosomes were prepared and analyzed according to previously
published methods with some modifications (Wise et al., 1992). Cells were seeded
into 100 mm tissue culture dishes and treated with zinc chromate as described
above. Before harvesting, 0.1 µg/mL demecolcine was added to each dish to arrest
cells in metaphase. Demecolcine was added for 1 hour for human cells and for five
hours for whale cells. Demecolcine treatment period is optimized for various cell
lines and doubling times to ensure the cell population is enriched with metaphase
cells without over-condensation of chromatids that will impede chromosome
visualization. After 24 hours or 120 hours of exposure, media and treatment were
rinsed from the dishes and cells were released from the plate with 0.25% trypsinEDTA. Cells were washed in PBS, treated with hypotonic 0.075 M potassium
chloride for 17 minutes, and fixed in Carnoy’s fixative for 20 minutes. Fixative was
changed twice before preparing slides. Fixed cells were then dropped onto wet
glass slides and dried at 30º C, 30% humidity. Slides were stained with Giemsa
and glass cover slips were applied. Chromosomes were counted in at least 100
metaphases

per

concentration.

Normal

human

lung

cells

contain
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chromosomes. Normal diploid sperm whale and bowhead whale cells contain 42
chromosomes. Any metaphases with greater or fewer than the normal
chromosome complement were counted as aneuploid.
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Evidence of spindle assembly bypass including centromere spreading,
premature centromere division, and premature anaphase was recorded. A
minimum of 100 diploid metaphases per concentration were analyzed and
abnormal centromere separation events were recorded in all metaphases
encountered during analysis. Three experiments were analyzed.

Protein Analysis
Cells were seeded in tissue culture dishes and treated with zinc chromate
as described above. Cell-equivalent whole cell protein analysis was performed as
previously published (Speer et al., 2021). At the end of Cr(VI) exposure period,
cells were released from dishes by incubation in 0.25% trypsin-EDTA. Cells were
collected, washed in PBS, and counted with Beckman Coulter Multisizer 4e. Cells
were lysed in RIPA buffer supplemented with 100X HALT protease and
phosphatase inhibitor cocktail. Cell lysis was centrifuged 10 minutes at 14,000 rpm
and supernatant was collected and prepared with 4X protein sample loading buffer.
Protein samples in loading buffer were heated for 10 minutes at 70º C and stored
at -20º C. Prepared sample volumes equivalent to 50,000-75,000 lysed cells
(antibody-dependent)

was

loaded

into

Mini-Protean

TGX

gels.

After

electrophoresis, protein was transferred onto 0.45 µm nitrocellulose membrane in
ice cold transfer buffer with 10-20% methanol (antibody-dependent). Membrane
was probed with primary antibodies and secondary near-infrared antibodies.
Membranes were scanned using Odyssey CLx scanner and analyzed with Li-Cor
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Image Studio software. All primary antibodies were verified using positive and
negative controls.
Cytoplasmic and nuclear protein extractions were performed with NE-PER
nuclear and cytoplasmic extraction reagents according to manufacturer’s
instructions. Cells were harvested and counted as described above for whole cell
extraction. Cell pellets were re-suspended ice-cold CERI (cytoplasmic extraction
reagent I) supplemented with 100X Halt protease and phosphatase inhibitor,
vortexed vigorously for 15 seconds and incubated on ice 15 minutes. Ice-cold
CERII (cytoplasmic extraction reagent II) was added and tube was vortexed for 5
seconds, incubated on ice for 1 minute, vortexed for 5 seconds, and centrifuged at
14,000 RPM for 5 minutes. Cytoplasmic supernatant was isolated and stored on
ice until preparation with 4X protein sample loading buffer as for whole cell protein
samples. Nuclear fraction was resuspended in NER (nuclear extraction reagent)
supplemented with 100X Halt protease and phosphatase inhibitor. Tubes were
vortexed on highest setting for 15 seconds every 10 minutes for a total incubation
time of 40 minutes. Samples were centrifuged at 14,000 RPM and nuclear fraction
was prepared with 4X protein sample loading buffer as for whole cell extractions
and stored at -20º C.

Protein Half-Life Analysis
Protein half-life analysis was performed as previously published (Speer et
al., 2021) with some modifications. Cells were seeded in 100 mm tissue culture
dishes and treated with zinc chromate as described above at the final
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concentrations of 0 or 0.2 µg/cm2. Treatment durations were 24, 72, and 120
hours. At the end of exposure time, cells were treated with cycloheximide at final
concentration of 10 µM. Cells were harvested at 0, 2, 4, 6, and 8 hours after
cycloheximide addition and whole cell protein was analyzed according to the
Protein Analysis method above. Protein half-life was calculated from the
exponential best fit curve of protein levels after 0, 2, 4, 6, and 8 h cycloheximide
using the equation, Rate = (LN(0.5))/b, where the best fit line equation is y=aebx.

RNA Extraction, cDNA synthesis, and RT-qPCR
RNA analysis was performed as previously published (Speer et al., 2021).
After cell seeding and treatment as described for protein analysis, cells were
released from dishes by incubation in 0.25% trypsin-EDTA. Cells were collected
and washed in PBS. Total RNA was extracted using mirVana miRNA isolation kit
according to manufacturer’s instructions. Cells were lysed with lysis binding buffer
included in the kit, lysate was kept on ice, and homogenized. RNA was extracted
with acid-phenol:chloroform, isolated by glass-fiber filter, washed with mirVana kit
reagents, and RNA was eluted from the filter. Total RNA quality and quantity was
measured by spectrophotometry on NanoDrop instrument. Samples were stored
at -80º C.
Total RNA was reverse transcribed to single-stranded cDNA using a HighCapacity cDNA Reverse Transcription Kit according to manufacturer’s instructions.
2X master mix was prepared containing random primers and reverse transcriptase.
An equivalent amount of RNA across all experiment conditions, up to the maximum
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of 2 µg per reaction, was added to master mix for each sample. Control samples
with no reverse transcriptase and no input RNA were included with each
experiment. Reverse transcription was performed on a Biometra thermocycler.
cDNA was stored at -20ºC for no longer than one week before RT-qPCR analysis.
RT-qPCR was performed using TaqManÔ 20X RNA Assays and TaqManÔ
Universal Master Mix II, with UNG or TaqMan Fast Advanced Master Mix, with
UNG. Endogenous mRNA (GAPD) and target mRNA were analyzed in duplex. RTqPCR reactions were performed in triplicate and controls for no reverse
transcriptase, no RNA input, and no cDNA template were included for each of three
independent experiments. Quantitation was performed on StepOne Plus RealTime PCR System. Results were normalized by ∆∆Ct method and expressed as
relative quantification compared to untreated control (∆Ct = Ct gene target – Ct
endogenous control; ∆∆Ct = ∆Ct sample 1 - ∆Ct calibrator (untreated control); Fold
change = 2- ∆∆Ct). The calibrator has a relative quantification of 1. Relative
quantification value of 10 means the gene is 10 times more expressed, while a
value of 0.1 means 10 times less expressed.

MicroRNA Analysis
MicroRNA was analyzed by RNA sequencing as previously published
(Speer et al., 2022) Total RNA samples were extracted as described above and
analyzed by University of Louisville CGeMM DNA Facility Core. Library preparation
was performed using the TruSeq Small RNA Library Prep Kit v2 with gel
purification followed by library validation and quantification to create miRNA

40

libraries from 0.5–2 μg total RNA. 1 × 75 bp sequencing was performed using the
NextSeq 500 High Output v2 (75 cycles) kit on the Illumina NextSeq500
instrument. At least ten million reads per sample were generated.
Bioinformatics was performed as described in Speer et al., 2022. Fastxtoolkit was used to filter reads (http://hannonlab.cshl.edu/fastx_toolkit/) (Hannon,
2009). Base calls that show a Phred score < 20 (i.e., base call error rate > 1%)
were subsequently trimmed from both ends of a sequencing read to preserve the
longest section of a high-quality sequence read. Reads with base call quality <20
for over 25% of the remaining base calls were removed. For all data filtering steps,
sequencing reads with lengths <15 nucleotides were discarded. Sequencing reads
were mapped to human non-coding RNA reference transcriptome (Ensembl
GRCh38) using the Bowtie2 (Kim et al., 2013) ‘end-to-end’ mode, followed by
discarding transcriptome mapping results that yielded mapping scores <20 (i.e., >
1% error rate) using SamTools (Li and Durbin, 2009; Li et al., 2009). Expression
profiles for each sample were made using custom Perl scripts. Transcripts
identified as “miRNA” in the Ensembl “transcript_biotype” database (Ensembl
Version 98) were used in analyses.
Four technical replicates were analyzed for each experimental timepoint
and Cr(VI) concentration. All miRNAs with fewer than 10 total reads were removed
from analysis. Raw reads were normalized by multiplying the ratio of 1,000,000
over the sum of all its read counts. Linear mixed effect models were used to identify
differentially expressed miRNAs. Cr(VI) concentration and exposure time were set
as fixed effects and experiment as random effects. Each treatment concentration
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was compared to the 0 μg/cm2 zinc chromate control at its respective time point.
For each miRNA, diagnostic plots were used to ensure the assumption of
heterogeneity of the variance and normality were maintained. If not, logtransformation of the miRNA expression was used for statistical analysis.
Adjusted p-values were determined using the Benjamini-Hochberg false discovery
rate (FDR). All statistical analyses were carried out in R software (Version 4.0.0)
using the R “nlme” package. Significantly different regulation was determined by
an adjusted p value <0.01. In some cases, the mean counts of miRNAs were
reported as ‘0’ in the control or treatment groups and so 0.1 was added to all
miRNA means to avoid errors in Log2(Fold change) calculation. Also, some
adjusted p-values were reported as 0, therefore, “0.0001” was added to all values
to allow for Log(adjusted p-value) calculation.
Centrosome-related genes were identified using the Kyoto Encyclopedia of
Genes and Genetics (KEGG) online database (https://www.genome.jp/kegg/) and
relevant publications. For each gene of interest, potential targeting miRNAs were
searched using miRSystem database (Lu et al., 2012). All potential gene-targeting
miRNAs were then compared to the data of significantly up- and down-regulated
miRNAs.
siRNA Transfection
Cells were seeded into 60 mm tissue culture dishes and allowed to plate for
24 h. Transfection was performed using the Dharmacon DharmaFECT 1 reagent
as previously published (Speer et al., 2021). The selected siRNA stock was diluted
to 5 µM with 1X siRNA buffer. In separate tubes, siRNA (Tube 1) and

42

DharmaFECT transfection reagent (Tube 2) were diluted in serum-free, antibioticfree media and incubated for 5 minutes. The contents of Tube 1 and Tube 2 were
mixed and incubated for 20 minutes. Antibiotic-free medium was added at the
appropriate volume and transfection solution containing siRNA and transfection
reagent was applied to each well. The final concentration of siRNA was 25 nM and
the transfection reagent final concentration in the dish was 1 µl/ml. Cells were
incubated for 24 h to allow transfection, then dishes were aspirated and fresh
media were added and cells were treated with zinc chromate for 24 h (48 h total
transfection time) or 120 h (144 h total transfection time). After treatment period,
cells were harvested for protein analysis or chromosome analysis. Protein
knockdown was verified using protein analysis method above.

Centrosome Analysis
Centrosomes were analyzed by immunofluorescence as previously
published (Holmes et al., 2006). Bowhead whale cells were seeded on glass, FNCcoated chamber slides. Cells were allowed 72 hours to enter logarithmic growth
before treatment with zinc chromate at final concentration of 0 or 0.2 µg/cm2 zinc
chromate. After 24 h or 120 h exposure, media were aspirated and cells were
washed twice with microtubule stabilizing buffer (3 mM EGTA, 50 mM PIPES, 1
mM MgSO4, 25 mM KCl), fixed with -20 ºC methanol for 10 minutes and allowed
to air dry completely. Cells were rehydrated for 3 minutes in 0.05% Triton X-100,
followed by 30 minutes of blocking with centrosome buffer (5% normal goat serum,
1% glycerol, 0.1% bovine serum albumin, 0.1% fish skin gelatin, 0.04% sodium
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azide in PBS). Cells were incubated with anti-g-tubulin antibody and a-tubulin-FITC
antibody for 1 hour each, washing in PBS three times between each incubation.
Cells were incubated with isotype-specific Alexa Fluor 555 for g-tubulin
visualization. Cells were washed and aged overnight before mounting coverslips
with Prolong Diamond Antifade Mountant with DAPI. Slides were analyzed by
fluorescent microscopy on Olympus BX51 and representative images were
obtained by Applied Spectral Imaging GenASIS software version 7.1.0.1277.
Centrosome number was counted in 1000 interphase and 100 mitotic cells per
treatment. Two experiments were analyzed.

Chromium Uptake Assay
Chromium uptake was measured as previously reported (Speer et al.,
2019). Whale cells were seeded into 60 mm dishes and treated as described
above. Harvests were performed at the time of treatment (0 h) and after 24 h and
120 h of exposure. Extracellular chromium was analyzed from culture media
passed through a 0.2 µm filter. To obtain intracellular samples, plates were rinsed
with 1X PBS and cells were released using 0.25% trypsin-EDTA. Cell counts and
cell diameter were recorded. Cells were washed twice in 1X PBS and suspended
in 1 ml 0.075 M hypotonic potassium chloride for 5 minutes. One milliliter 2%
sodium dodecyl sulfate was added for 15 minutes to rupture the cell membrane
and the suspension was sheared through an 18G needle 7 times. Lysate was
filtered through a 0.2 µm filter. All samples were diluted in 2% nitric acid.
Extracellular and intracellular chromium was analyzed by atomic absorption
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spectroscopy with a Perkin Elmer 900Z graphite furnace atomic absorption
spectrometer (GFAAS) using Syngistix Software. Calibration was performed using
chromium standards at 0, 5, 10, 20, 40 and 80 ppb of chromium (PerkinElmer
Pure,1,000 µg/ml, 2% HNO3). The wavelength used for chromium was 357.87 nm.
All points were within the range of detection and trace free 2%. The limit of
detection for chromium was 0.004 µg/l. Three experiments were analyzed per cell
line.

Cell Cycle Analysis
Cell cycle analysis was performed using flow cytometry using published
methods (Xie et al., 2009) with modifications. Cells were seeded in 100 mm tissue
culture dishes and treated with zinc chromate as described above for 24 h or 120
h. One hour before end of treatment, NCS (400 ng/ml final concentration) was
applied to the positive control dish and incubated for 30 minutes in the dark,
followed by 30 minutes recovery time in fresh media. At the end of treatment time,
media was collected in 50 ml conical tubes to ensure analysis of all cells. Adherent
cells were released from dishes with 0.25% trypsin-EDTA and collected and
combined with harvested media. Cells were centrifuged to a pellet at 1,000 RPM
for 5 minutes, then resuspended in 5 ml PBS and counted. One million cells for
each treatment condition was saved in a new tube and resuspended in 0.5 ml of
PBS. Cells were fixed in 4% PFA (paraformaldehyde) on ice, 15 minutes. Cells
were pelleted by centrifugation, washed with PBS, and centrifuged again. Cells
were resuspended in 0.5 ml PBS and combined with 70% ethanol, added drop-
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wise during gentle vortexing. Fixed cells were centrifuged, resuspended in 1 ml
70% ethanol and stored at -20º C until analysis. Cell cycle analysis was performed
using propidium iodide to quantify DNA content. Flow cytometry was analyzed
using FlowJo software to determine percentage of cells in G1, S, or G2/M phase.

Karyotype Analysis
Karyotype analysis using Giemsa banding (g-banding) was used to confirm
cell line identity. G-banding creates signature staining patterns on chromosomes
to enable identification of each chromosome and to characterize a cell line. Cells
were seeded into a tissue culture flask and at 70-80% confluency cells were
arrested in metaphase by demecolcine. Media was collected and cells were
released using 0.25% trypsin-EDTA. Cells were centrifuged at 1,000 RPM, media
was aspirated, and cells were resuspended in hypotonic 0.075 M potassium
chloride for 17 minutes, then fixed in Carnoy’s fixative for 20 minutes. Fixative was
changed twice before preparing slides. Fixed cells were then dropped onto wet
glass slides and dried at 30º C, 30% humidity. Cells were baked in 95º C oven for
45 minutes. Chromosomes were stained by digesting the cells with trypsin (1:250)
in Gurr’s buffer approximately 30 seconds – 1 minute and then neutralized in Gurr’s
buffer with 2% fetal bovine serum. Slides were dipped 3-4 times in Gurr’s buffer
(pH 7.0) then 70% ethanol, 95% ethanol and Gurr’s buffer (pH 6.8) before staining
approximately 3 minutes in Geimsa stain. Slides were cover-slipped and imaged
using an Applied Spectral Imaging microscope and software. Ten metaphases
were assessed per analysis.
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Statistical Analysis
All values are expressed as the mean ± SEM (standard error of the mean).
Clonogenic survival, aneuploidy, spindle assembly checkpoint bypass, cell cycle
analysis, and chromium uptake were analyzed by single factor ANOVA (a=0.05)
to determine the significance of zinc chromate treatments within each time point.
For cell cycle analysis, Dunnett’s multiple comparisons test (a=0.05) was used to
assess differences between treatments and controls in each cell phase. Two-tailed
Student’s t-tests (unequal variance) were performed for all other assays to
determine differences between each chromate concentration and the untreated
control for each time point.
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CHAPTER 3: RESULTS

AIM 1: PARTICULATE HEXAVALENT CHROMIUM-INDUCED
SECURIN DYSREGULATION DRIVES NUMERICAL CHROMOSOME
INSTABILITY IN HUMAN LUNG CELLS

BACKGROUND
Particulate hexavalent chromium [Cr(VI)] is a potent lung carcinogen.
Widespread industrial usage causes Cr(VI) to be both an occupational exposure
risk as well as an environmental contaminant whose dangers are recognized by
prominent placement on the ATSDR Substance Priority List (ATSDR, 2019).
However, despite well-known cancer risks posed by Cr(VI), its carcinogenic
mechanisms are not well understood. A driving mechanism in Cr(VI)
carcinogenesis is chromosome instability (Kondo et al., 1997; Hirose et al., 2002;
Holmes et al., 2008; Salnikow and Zhitkovich, 2008; Wise et al., 2010; Proctor et
al., 2014). We previously reported particulate Cr(VI) induces numerical
chromosome instability in human lung cells after prolonged (> 48 h) exposure but
not after acute (24 h) exposure (Holmes et al., 2006; Holmes et al., 2010). We also
found Cr(VI)-induced numerical chromosome instability was heritable at a cellular
level, and consistent with our previous reports, required at least 48 h of exposure
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to occur (Wise et al., 2018). How Cr(VI) causes numerical chromosome instability
is currently unknown.
A central regulator for numerical chromosome instability is securin (Zhou et
al., 1999; Jallepalli et al., 2001; Chao et al., 2006). Securin regulates separase
activity through inhibitory binding and the securin-separase complex is present in
yeast, plants, and animals (Cohen-Fix et al., 1996; Funabiki et al., 1996; Zhou et
al., 1999). Securin is best known as an anaphase inhibitor that regulates separase
activity at centromeres and thus protects faithful chromosome segregation
(Yamamoto et al., 1996; Funabiki et al., 1996a; Cohen-Fix et al., 1996; Jallepalli
et al., 2001; Waizenegger et al., 2002). Indeed, securin has been well-described
for inhibiting sister chromatid disjunction (Uhlmann et al., 1999; Ciosk et al., 1998).
Interaction with securin inhibits the active site of separase until timely degradation
of securin releases this block (Funabiki et al., 1996; Cohen-Fix et al., 1996; Zhou
et al., 1999; Hornig et al., 2003; Waizenegger et al., 2000). At the metaphaseanaphase transition, separase-bound securin is degraded, inducing separase
protease activity to cleave the SCC1/RAD21 subunit of cohesin. The opening of
the cohesin ring releases sister chromatid conjunction and allows chromatid
segregation into daughter cells. Uncontrolled separase activity at the centromeres
causes abnormal mitosis and aneuploidy (Zhang et al., 2008; Shindo et al., 2021).
Securin has another key role in maintaining numerical chromosome fidelity
through centrosome duplication control (Inanç et al., 2010; Tsou and Stearns,
2006). The securin-separase complex localizes to centrosomes and separase
activity there causes centriole disengagement (Agircan and Schiebel, 2014; Tsou
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and Stearns, 2006). Centrioles are held together by cohesin and kendrin, both of
which are separase substrates. Daughter centriole disengagement is the licensing
step for centrosome duplication (Tsou and Stearns, 2006) and maintenance of
centrosome number requires controlled timing of this occurrence. At the
centrosomes, loss of securin inhibitory function on separase activity leads to
centrosome

amplification.

Centrosome

amplification

drives

numerical

chromosome instability by generating aberrant spindle poles, kinetochoremicrotubule disruption, and asymmetrical chromatid segregation (Baum et al.,
1988; Sluder and Nordberg, 2004; Fukasawa, 2009; Jusino et al., 2018).
We previously demonstrated prolonged Cr(VI) exposure induces premature
chromatid separation, premature centriole disengagement, and centrosome
amplification (Holmes et al., 2006; Wise et al., 2006; Holmes et al., 2007; Martino
et al., 2015). These defects can lead to numerical chromosome instability, yet the
mechanistic cause is unknown. Securin has been shown to be vulnerable to DNAdamaging agents (Zhou et al., 2003; Chou et al., 2005) and experimental securin
modulation can induce centrosome amplification and CIN (Yu et al., 2003; Chou
et al., 2005; Kim et al., 2007; Tsou and Stearns, 2006; Mora-Santos et al., 2013).
We investigate securin as a target of Cr(VI) and as a potential key in Cr(VI)-induced
premature chromatid separation, premature centriole disengagement, centrosome
amplification, and numerical chromosome instability.
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RESULTS
Prolonged Cr(VI) exposure causes securin protein loss.
We previously reported prolonged (120 h) exposure to zinc chromate
induces centrosome amplification and abnormal centrioles (Holmes et al., 2009;
Martino et al., 2015). Acute (24 h) exposure did not induce changes in
centrosomes or chromosome instability. Securin is a central regulator for
centrosome maintenance and prevents abnormal centriole splitting, thus we
investigated if securin is affected by acute or prolonged zinc chromate exposure.
After 24 h and 120 h zinc chromate exposure, securin protein levels were
measured by western blot. We found 24 h exposure caused securin increase. Cells
exposed to 120 h concentrations of 0.1, 0.2, and 0.3 ug/cm2 zinc chromate showed
reductions of securin levels to 48.5%, 31%, and 15.3% relative to untreated
controls (Figure 5).
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Figure 5. Securin protein levels in human lung cells after zinc chromate exposure.
This figure shows prolonged Cr(VI) exposure decreased securin levels. (A)
Representative western blot for securin. Alpha-tubulin was used as a loading
control. (B) Securin whole cell protein levels decreased after 120 h Cr(VI)
exposure. Data are expressed as percent of untreated control cells and reflect the
mean of three independent experiments. Error bars = SEM. *Significantly different
from control group (p < 0.05).
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Prolonged Cr(VI) exposure causes loss of securin function.
We have shown 120 h zinc chromate exposure to human lung cells causes
a loss of securin protein which becomes more severe at higher concentrations.
Securin and separase function are critical to proper cell function and thus are
tightly controlled and protected by redundant pathways (Stemmann et al., 2001;
Nagao et al., 2002; Hellmuth et al., 2015). We sought to determine if cells cope
with zinc chromate exposure by retaining securin function under lower protein
levels. Securin function restrains separase enzyme activity, and so we investigated
three measures of separase activity: 1) separase autocleavage, 2) kendrin
cleavage, 3) Scc1 cleavage. When securin is released from separase, separase
becomes its own substrate and cleaves itself (Waizenegger et al., 2000). Separase
autocleavage is observable on western blots as a full length, 220 kDa, band and
quickly migrating bands of smaller protein fragments (Figure 6A). After 24 h,
separase 220 kDa, 170 kDa, and 70 kDa bands are similar to control levels at all
zinc chromate concentrations we tested (Figures 6B, 6C, 6D). However, 120 h
exposure caused the 170 kDa protein fragment to increase to 200%, 310%, and
380% of control levels with 0.1, 0.2, and 0.3 ug/cm2 zinc chromate concentrations,
respectively (Figure 6C). Separase fragments of 70 kDa increased to 220%, 420%
and 430% of control levels, respectively (Figure 6D). These data indicate
autocleavage increases with prolonged Cr(VI) exposure, thus securin inhibition of
separase cleavage activity is not maintained at these zinc chromate
concentrations. Figure 6E shows the levels of separase full-length and 170-kDa
fragment relative to control levels.
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Figure 6. Separase protein levels in human lung cells after zinc chromate
exposure. This figure shows prolonged Cr(VI) exposure induced separase
cleavage. (A) Representative western blot for separase. Alpha-tubulin was used
as a loading control. (B) Separase full length protein levels increased slightly after
120 h Cr(VI). (C-D) Cleaved separase protein levels increased after 120 h Cr(VI).
(E) Comparing full length and cleaved levels showed differences in cleavage
activity between 24 h and 120 h exposures. Data are expressed as percent of
untreated control cells and reflect the mean of three independent experiments.
Error bars = SEM. *Significantly different from control group (p < 0.05).
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The specificity of western blot antibody visualization does not allow us to
measure total separase levels. To determine if increased cleavage products are a
consequence of increased separase expression, we measured separase mRNA
levels after 24 and 120 h of zinc chromate exposure. RT-qPCR results show
separase mRNA levels were reduced at all time points and concentrations of zinc
chromate exposure (Figure 7). 24 h exposure to 0.1, 0.2, and 0.3 ug/cm2 zinc
chromate resulted in 0.761, 0.683, and 0.564 expression relative to compared to
controls, versus 0.412, 0.145, and 0.085 of control levels at 120 h, respectively,
indicating a downregulation. Thus, observed increases in separase cleavage
products are not likely caused by increased separase protein production and can
properly serve as an indicator of increased separase autocleavage.
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Figure 7. Separase mRNA quantified by RT-qPCR after 24 and 120 h zinc
chromate exposure. This figure shows Cr(VI) exposure decreased separase
mRNA after 24 h and 120 h. *Significantly different from control group (p > 0.05).
Data are expressed as relative expression compared to untreated control cells and
reflect the mean of three independent experiments with three technical replicates
each. Error bars = SEM. *Significantly different from control group (p < 0.05).
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Securin functions to control cleavage of kendrin by separase. Kendrin is a
large coiled-coil protein with the essential role in centrosome maintenance of
supporting centriole engagement (Matsuo et al., 2010; Matsuo et al., 2012).
Centrioles must remain engaged throughout the cell cycle until after anaphase
when they split for the purpose of centrosome duplication. Aberrant centriole
separation during G2 phase can cause overduplication of centrosomes and lead
to centrosome amplification (Tsou et al., 2009; Inanç et al., 2010; Loncarek et al.,
2010). Kendrin cleavage can be observed by western blot as a full-length band of
360 kDa and a 125 kDa N-terminal fragment (Figure 8A). Figure 8B shows full
length kendrin protein levels. 24 h exposure induced slight increases in protein,
but 120 h exposure to 0.1, 0.2, and 0.3 ug/cm2 zinc chromate resulted in full length
protein levels of 75.7%, 56.4% and 55.8% of control levels. Cleaved protein at 120
h increased to 118.3%, 159.9% and 152.2%. of control levels (Figure 8C). Thus,
120 h zinc chromate exposure resulted in higher cleaved versus full-length kendrin
levels, indicating increased separase activity and loss of securin function.
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Figure 8. Full Length and cleaved kendrin protein after 24 and 120 h zinc chromate
exposure. This figure shows prolonged Cr(VI) induced kendrin cleavage. (A)
Representative western blot showing full-length and cleaved kendrin bands.
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Alpha-tubulin was used as a loading control. (B) Full length kendrin levels
decreased after 120 h Cr(VI). (C) Cleaved kendrin protein levels increased after
120 h. (D) Comparing full-length and cleaved protein levels shows cleavage
activity changed after 120 h compared to 24 h. *Significantly different from control
group (p > 0.05). Data are expressed as percent of untreated control cells and
reflect the mean of three independent experiments. Error bars = SEM.
*Significantly different from control group (p < 0.05).
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Securin functions to inhibit separase from cleaving the SCC1 subunit of
cohesin. Cohesin rings are present at the centrioles to link them together during
interphase and prevent premature disengagement (Schockel et al., 2011). The full
length SCC1 protein appears as a 130 kDa band, while its cleavage product
migrates at 90 kDa. We measured SCC1 cleavage as a ratio of cleaved to full
protein. In whole cell extracts, zinc chromate did not significantly alter SCC1
cleavage at any timepoint or concentration (Figure 9B). This outcome may be
because the vast majority of cohesin is sequestered in the nucleus and not cleaved
by separase during interphase. We propose centriole-associated cohesin is
cleaved by prematurely active separase in interphase cytoplasm, thus we used
cytoplasmic protein fractions to analyze SCC1 cleavage, but protein levels were
too low to be detected by western blot (data not shown). We measured SCC1 in
nuclear fragments and found prolonged Cr(VI) exposure increased the ratio of
cleaved/full-length protein (Figure 9C). Though the result was not statistically
significant, 120 h exposure to 0.1, 0.2, and 0.3 µg/cm2 zinc chromate increased
the ratio of cleaved/full-length protein to 102.9%, 148.1%, and 152.0% compared
to control, respectively.
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Figure 9. Full-length and cleaved SCC1 protein after 24 and 120 h zinc chromate
exposure. SCC1 cleavage was measured in Cr(VI)-exposed cells versus control
cells. (A) Representative western blot showing full-length and cleaved SCC1
bands from whole cell extract. Alpha-tubulin was used as a loading control. (B) The
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ratio of cleaved/full-length SCC1 was not significantly altered by Cr(VI) in whole
cell lysates. (C) The ratio of cleaved/full-length nuclear SCC1 was not significantly
altered but show a strong increasing trend, indicating increased cohesin cleavage.
Data are expressed as percentage of untreated control cells and reflect the mean
of two independent experiments. Error bars = SEM. No condition was significantly
different from control group.
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Kendrin and cohesin are responsible for maintaining centriole engagement
throughout the cell cycle, until timely release in late mitosis or early G1 phase
(Agircan et al., 2014). We previously demonstrated zinc chromate induces
centriole disruption, including abnormal centriole disengagement in G2 phase
(Martino et al., 2015). Thus, our results showing kendrin cleavage increased and
nuclear cohesin cleavage increased while securin levels decreased are consistent
and indeed help to explain previous results indicating zinc chromate targets
centriole linker maintenance.

Prolonged Cr(VI) exposure causes loss of cyclin B1 protein.
Securin is the canonical separase inhibitor. However, timely separase
activation is so critical to cellular integrity that multiple redundant mechanisms exist
to control separase. Redundant inhibition is evidenced by studies showing securin
knockout in human and mouse cells can persist and grow relatively unaffected
(Mei et al, 2001; Pfleghaar et al., 2005). Cyclin B1 acts as a secondary separase
inhibitor (Gorr et al., 2005; Hellmuth et al., 2015). Cyclin-dependent kinase 1
(Cdk1) is activated by its partner, cyclin B1, to phosphorylate separase, making
separase susceptible to aggregation and precipitation and thus inactive (Hellmuth
et al., 2015). Also, the Cdk1-cyclin B1 complex binds to separase which also
renders it inactive but primed for activation (Hellmuth et al., 2015). Thus, we
measured cyclin B1 protein levels after 24 h and 120 h of 0.1, 0.2, and 0.3 ug/cm2
zinc chromate exposure. Again, no significant change was observed after acute
exposure, but after prolonged 120 h exposure, cyclin B1 levels were reduced to

64

43.7%, 24.5%, and 12.7% of control values (Figure 10). These data indicate Cr(VI)
reduces securin and also inhibits secondary compensation by cyclin B1.
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Figure 10. Cyclin B1 protein levels in human lung cells after zinc chromate
exposure. This figure shows prolonged Cr(VI) exposure decreased cyclin B1
levels. (A) Representative western blot for cyclin B1. GAPDH was used as a
loading control. (B) Cyclin B1 whole cell protein levels decreased after 120 h Cr(VI)
exposure. Data are expressed as percent of untreated control cells and reflect the
mean of three independent experiments. Error bars = SEM. *Significantly different
from control group (p < 0.05).
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Cyclin B1 levels fluctuate with the phases of the cell cycle such that levels
are low in G1, begin to rise in S, peak in early mitosis, and drop with degradation
at the metaphase-to-anaphase transition. Securin levels rise during S phase and
are depleted at the initiation of anaphase. One interpretation of observed securin
and cyclin B1 losses is these data may be evidence of a cell cycle effect in which
Cr(VI) causes a large proportion of cells to accumulate in G1 phase. To pursue
this question, we performed cell cycle analysis by flow cytometry and measured
cell cycle phase by the DNA content. Cr(VI) exposure for 24 h and 120 h did not
enrich the population of G1 cells. In fact, consistent with a DNA damage exposure,
Cr(VI) caused increase in G2/M populations (Figure 11). G2 and M are the phases
at which securin and cyclin B1 levels should be the highest, providing confidence
that measured protein loss is not due to cell cycle disruption.
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Figure 11. Percent of human lung cells in each cell phase after zinc chromate
exposure. This figure shows Cr(VI) decreased the percentage of cells in G1 and
increased the percentage of cells in G2/M. Data are expressed as percent of
untreated control cells and reflect the mean of three or four independent
experiments. Error bars = SEM. **Significantly different from control group (p <
0.001).
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Securin knockdown with acute Cr(VI) exposure
recapitulates aneuploidy observed after prolonged Cr(VI) exposure.
We previously reported 120 h exposure to 0.2 ug/cm2 zinc chromate caused
aneuploid metaphases to increase to 44% compared with control levels of 8-13%
(Holmes et al., 2010). Our hypothesis is Cr(VI)-induced aneuploidy is caused by
loss of securin protein. Zinc chromate exposure for 24 h did not reduce securin
protein levels or induce aneuploid metaphases (Holmes et al., 2010). By artificially
reducing securin alongside 24 h Cr(VI) exposure, numerical CIN may be induced
similarly to prolonged Cr(VI) exposures which incur securin loss. We used securintargeting siRNAs to knockdown securin protein levels and then exposed human
lung cells to 0.2 ug/cm2 zinc chromate for 24 h. Figure 12 shows securin levels
after knockdown by two different siRNAs. Aneuploidy was not significantly
increased by 24 h zinc chromate exposure alone, consistent with our earlier
findings. 24 h exposure did increase the percent of aneuploid metaphases to
15.9% and 20.2% after knockdown with siRNAs #1 and #2, respectively. Securin
knockdown alone increased aneuploidy slightly. Of note, non-targeting siRNA
transfection caused cell death and increased aneuploidy rates compared with
control, which could be interpreted as an effect of transfection.
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Figure 12. Aneuploidy after 48 h securin knockdown and 24 h zinc chromate
exposure. This figure shows securin knockdown increases aneuploidy after acute

Securin knockdown chrom damage

Cr(VI) exposure. (A) Securin protein loss by siRNA targeting was confirmed.
GAPDH was used as a loading control. (B) Percent of aneuploid metaphases
increased after securin knockdown and acute Cr(VI) exposure. Data reflect one
experiment.
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Securin knockdown with acute Cr(VI) exposure recapitulates spindle
assembly checkpoint bypass observed after prolonged Cr(VI) exposure.
Spindle assembly checkpoint prevents cell cycle progression into anaphase
until all kinetochores are properly attached to microtubules. Proper separase
regulation will inhibit enzyme activity towards centromeric cohesin until anaphase.
Thus, metaphase abnormalities including centromere spreading, premature
centromere division, and premature anaphase are evidence of spindle assembly
checkpoint bypass and aberrant separase activity, both of which cause aneuploidy.
As described by Holmes et al. (2010), centromere spreading is defined as
dissociation of chromatids at the centromere but not at the rest of the chromosome;
premature centromere division is characterized by at least one chromosome in a
metaphase spread that is separated from its sister chromatid while at least one
chromosome is connected to its sister chromatid; premature anaphase is defined
as all chromosomes separated from their sister chromatids. We previously
reported 120 h exposure to 0.2 ug/cm2 zinc chromate caused 5% centromere
spreading, 21% premature centromere division, and 13% premature anaphase
while controls displayed 1% premature centromere division and 1% premature
anaphase (Holmes et al., 2010). Our hypothesis is loss of securin protein leads to
premature separase activity, which can result in cleavage of centromeric cohesin
before metaphase to anaphase transition. We used siRNA to knockdown securin
levels and then treated human lung cells for 24 h with 0.2 ug/cm2 zinc chromate.
Previous findings (Holmes et al., 2010) revealed no increase in SAC bypass was
measured after 24 h exposure. Consistent with Holmes et al., we measured 1%
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premature centromere division and 1% premature anaphase in both untreated and
treated cells without transfection. Securin knockdown increased the percentage of
metaphases exhibiting SAC bypass, and this was an effect consistent with each
siRNA (Figure 13). Securin siRNA #1 caused 2.9% premature centromere division
and 4.8% premature anaphase. Securin siRNA #2 caused 6% centromere
spreading and 2% premature anaphase. Non-targeting siRNA also caused
increased SAC bypass with 2% centromere spreading, 1% premature centromere
division, and 1% premature anaphase. Interestingly, zinc chromate exposure with
securin knockdown resulted in SAC bypass as low as control levels.
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Figure 13. Spindle assembly checkpoint bypass after 48 h securin knockdown and
24 h zinc chromate exposure. This figure shows securin knockdown increases
SAC bypass. This effect was not retained with addition of acute Cr(VI) exposure.
Percent of metaphases showing SAC bypass increased after securin knockdown
with both siRNAs. Data reflect one experiment.
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Prolonged Cr(VI) targets securin via a pre-translational mechanism.
In considering how zinc chromate reduces securin protein levels, one
possibility is that securin degradation is affected. Securin is degraded via the
anaphase-promoting complex/cyclosome (APC/C) during anaphase (Cohen-Fix et
al., 1996; Yamamoto et al., 1996; Tsou et al., 2006b), allowing activation of
separase. To measure securin protein degradation rates, we performed a
cycloheximide chase assay after 24, 72, and 120 h zinc chromate exposure. We
focused on 0.2 ug/cm2 zinc chromate exposure because it shows a strong
response in securin reduction after 120 h. We added the intermediate time point
of 72 h to detect potential key events in degradation leading up to the observed
120 h reduction of securin protein level. Securin protein half-life did not differ
between control and treated cells after 24, 72, or 120 h zinc chromate exposure
(Figure 14).
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Figure 14. Securin protein half-life in human lung cells after zinc chromate
exposure. This figure shows Cr(VI) did not change rates of securin degradation.
(A-C) Representative western blots for securin after cycloheximide (CHX)
treatment. GAPDH was used as a loading control. (A) Securin protein after 24 h
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Cr(VI). (B) Securin protein after 72 h Cr(VI). (C) Securin protein after 120 h Cr(VI).
(D) Representative plot of securin degradation over time on log base 2 scale (120
h zinc chromate exposure example). Solid line represents the securin signal and
dotted line represents the best fit line used for calculating the protein half-life. (E)
Securin half-life did not significantly change after zinc chromate exposure. Data
reflect the mean of three independent experiments. Error bars = SEM. No condition
was significantly different from the untreated control group.
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Our data show securin loss is not due to Cr(VI)-induced protein degradation,
thus we measured effects on securin at the pre-translational level by quantifying
securin mRNA using RT-qPCR after 24 and 120 h zinc chromate exposures. Slight
decreases in mRNA levels after 24 h were not statistically significant. However,
0.1, 0.2, and 0.3 ug/cm2 zinc chromate exposures at 120 h caused securin mRNA
expression levels of -0.52, 0.143, and 0.012, respectively (Figure 15). Together
these data show zinc chromate targets securin via pre-translational mechanisms
and does not change protein stability.
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Figure 15. Securin mRNA quantified by RT-qPCR after 24 and 120 h zinc chromate
exposure. This figure shows Cr(VI) exposure decreased securin mRNA after 24 h
and 120 h. *Significantly different from control group (p > 0.05). Data are expressed
as relative expression compared to untreated control cells and reflect the mean of
three independent experiments with three technical replicates each. Error bars =
SEM. *Significantly different from control group (p < 0.05).
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Summary
Cr(VI) is a well-known human carcinogen. Despite evidence of genotoxic
effects in humans, rodent studies, and cell culture, the molecular mechanism of
carcinogenesis remains unknown. Cr(VI) exposure causes SAC bypass, centriole
disengagement, centrosome amplification, and numerical CIN indicated by
aneuploid metaphases (Martino et al., 2015; Holmes et al., 2010; Wise et al., 2006;
Holmes et al, 2006). Studies show centriole disengagement leads to centrosome
amplification. Centrosome amplification is a driver of numerical chromosome
instability. Separase is the enzyme responsible for both centriole disengagement
and cohesin cleavage at centromeres which permits SAC bypass. This study
investigates how numerical chromosome instability may be induced through
disruption of the main separase regulatory protein, securin. Securin inhibition of
separase controls timing of cohesin and kendrin cleavage at centrioles. Thus
securin regulates centriole disengagement and cohesin cleavage at centromeres.
Disruption of securin can cause premature centromere spreading, centromere
division, and premature anaphase.
We show here 120 h zinc chromate exposure in human lung cells causes
dramatic decrease in securin protein levels. Protein half-life measurements show
securin degradation is not affected by Cr(VI) and cell cycle analysis shows
changes in securin protein are not explained by changes in the cell cycle. RTqPCR analysis of securin mRNA correlate with protein loss after 120 h, indicating
Cr(VI) causes reduction in securin gene expression.
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Depressed levels of securin protein may still be sufficient to control
separase, thus we used three markers of separase activity to analyze loss of
securin function. Upon securin release, separase becomes active and causes 1)
separase autocleavage, 2) kendrin cleavage, and 3) Scc1 cleavage. We show
separase autocleavage increases after 120 h zinc chromate exposure, indicating
separase activation. Separase mRNA quantification shows increased separase
activity is not due to increased separase expression, and separase mRNA actually
decreased after 120 h Cr(VI) exposure.
We found 120 h Cr(VI) caused increased kendrin cleavage. Kendrin is a
separase substrate present at the centrioles to support engagement and prevent
untimely centriole disengagement. Thus, abnormal kendrin cleavage provides
evidence for premature separase activity at the centrosomes. Variation in the
levels of cleaved kendrin fragments reduced statistical significance and may be
due to generation of fragments that run at variable speeds. Kendrin has A and B
isoforms that differ slightly in total molecular weights and whose cleavage products
have different sizes. Furthermore, Lee and Rhee (2015) identified 22 sites at which
Plk1 phosphorylates kendrin. Variation in protein phosphorylation will alter band
migration upon electrophoresis. A useful measurement of kendrin cleavage can be
performed by fluorescent reporter. Agircan et al. (2014) developed a peptide
consisting of a centrosome-localizing sequence and kendrin cleavage site flanked
by mCherry and eGFP peptides that caused an observable color change after
substrate cleavage by separase. This reporter would be a useful addition, but we
were not able to replicate this reporter for our study.
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We measured cleavage of the cohesin subunit, SCC1, after Cr(VI). We did
not find significant alteration of SCC1 cleavage. This result is consistent with
current knowledge regarding separase activity on cohesin. The portion of total
cohesin cleaved by separase is relatively small. Firstly, we propose premature
separase activity causes centriole disengagement in interphase cells, specifically
during Cr(VI)-induced G2 arrest. The majority of cohesin in the cell is associated
with chromosomes. Separase is largely excluded from the nucleus during
interphase due to the large size of the protein and a nuclear exclusion sequence
at its C-terminal (Sun et al., 2006) which prevents its activity in the nucleus. DNA
damage induces translocation of separase into the nucleus to aid in DNA damage
repair, and thus a small portion of cohesin specifically at DNA break sites may be
cleaved by separase (Kueng et al., 2006). Securin enables separase import into
the nucleus (Hornig et al., 2002) and so under lower securin levels, intranuclear
separase may be lower than usual after Cr(VI) exposure. Secondly, we observed
the effects of separase activity in mitotic cells through premature cohesin cleavage
at centromeres. The portion of cohesin cleaved by separase at mitotic
chromosomes is again relatively small. The majority of cohesin release along
chromosome arms is caused by separase-independent dissociation (Sumara et
al., 2002; Kueng et al., 2006) leaving only centromeric cohesin to be cleaved by
separase. Therefore, separase targets only a small percentage of total SCC1 in
both interphase and mitotic cells and changes in cleavage of this small portion are
difficult to measure by western blots in either whole cell or nuclear extractions. We
did observe a trend in increased cohesin nuclear cohesin cleavage. Perhaps by
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repeating nuclear cohesin measurements several more times, the trend might
become more prominent. Peptide reporters can be designed to measure SCC1
cleavage by spectrometry (Basu et al., 2009; Haass et al., 2015; Zhang et al.,
2014) but the production of these peptides was not feasible for this study. In our
cell system, evidence for premature separase activity at centromeres is best
demonstrated using SAC bypass analysis.
The role of securin in separase activity inhibition was shown with
chromosome analyses after securin knockdown by siRNA. Predictably, SAC
bypass was markedly increased after securin knockdown, but we were surprised
this effect was not enhanced with Cr(VI) exposure. Cr(VI)-treated knockdown cells
had SAC bypass events at the same level as untransfected control cells.
Centromeric cohesin is protected by shugoshin protein, so one possible
explanation is this protection from separase cleavage remained intact after 24 h
exposure. Consistent with the hypothesis securin loss causes numerical
chromosome instability, aneuploidy increased in securin-knockdown cells after
only 24 h Cr(VI) exposure. Securin siRNA #2 caused a 2-fold increase in
aneuploidy after zinc chromate exposure.
Securin knockout studies in human and mouse cells show securin is not
required for cell survival. Securin knockout mouse embryonic stems cells have
been shown to grow normally compared to wild type and efficiently arrest upon
colcemid exposure, indicating functional separase control in securin knockout cells
(Mei et al., 2001). Jallepalli et al. (2001) showed securin knockout in human
colorectal carcinoma cells (HCT116) causes chromosome instability. Pfleghaar et
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al. (2005) demonstrated that although securin-knockout HCT116 initially lose
chromosome stability, after several passages they regain chromosome stability
despite reduced separase activity and protein levels. However, results in this p53deficient cancer cell line are not necessarily representative of normal cell
response. Securin is dispensable because cells have redundant mechanisms for
separase control. Cyclin B1 is a secondary inhibitor that enables cells to cope with
securin loss. The Cdk1-cyclin B1 complex phosphorylates separase to inactivate
it, and also stably binds to separase to control its activity. We showed 120 h Cr(VI)
exposure reduced cyclin B1 levels, which helps explain how securin knockout cells
can cope relatively better than Cr(VI)-exposed cells. Overall, gene knockdown is a
helpful tool to provide support for the role of securin in human lung cells, but does
not precisely align with Cr(VI)-induced effects. Cr(VI)-induced cellular changes are
complex and likely synergistic, yet securin knockdown at 24 h mimics the critical
effects observed after 120 h Cr(VI) exposure. We attempted to rescue the effects
of 120 h Cr(VI) using siRNA knockdown of separase. However, separase
knockdown induced severe aneuploidy in untreated cells, including polyploidy and
endoreduplication (data not shown). Separase knockdown is hence unsuitable for
evaluating the role of securin disruption at prolonged timepoints.
In Aim 1 we show Cr(VI) targets securin by disrupting mRNA levels.
Reduced securin levels are not sufficient to control separase activity, evidenced
by increased substrate cleavage and consistent with previous reports of
centromere division and centriole disengagement. Additionally, securin loss is not
compensated by cyclin B1, as it is also lost upon Cr(VI) exposure. As a critical
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centrosome regulatory protein, securin emerges as a key target of Cr(VI).
Numerical chromosome instability and centrosome amplification are among the
most common cancer hallmarks. Uncovering protein players that contribute to the
mechanism of Cr(VI) carcinogenesis enhances understanding of environmental
causes of lung cancer.
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AIM 2: INVESTIGATING HEXAVALENT CHROMIUM-INDUCED
SECURIN LOSS

BACKGROUND
In Aim 1 we showed Cr(VI) reduces securin protein levels in human lung
cells after 120 h exposure. Securin loss was not explained by degradation because
protein half-life did not change between treated and untreated cells. However,
along with protein decrease, securin mRNA levels dropped significantly after 120
h of zinc chromate exposure, indicating securin is targeted at a pre-translational
level. To more fully understand the molecular mechanisms of Cr(VI)-induced
cellular changes, we seek to discover how Cr(VI) targets gene regulation.
Transcription factors are key regulatory tools for gene transcription. These proteins
contain DNA-binding domains that interact with gene promoter regions.
Transcription factors can promote or repress gene transcription by enabling or
hindering binding of RNA polymerase to the promoter region. Chromium alters
global gene expression and causes transcription inhibition (Raja et al., 2008;
Zablon et al., 2019; Wetterhahn et al., 1989); however, specific Cr(VI) effects on
securin transcription are not well known. Here we test the hypothesis, Cr(VI)
causes securin loss through alterations of transcription factor protein levels.
Securin protein is the product of the PTTG1 gene. PTTG1 is located at
chromosome 5q35.1 (Kakar, 1998). Its 5’ region contains no TATA box near the
transcription start site, but it does have a CAAT sequence at -474 bp and three
Sp1 box sites (Kakar, 1999). Securin gene promotion has been attributed to the
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transcription factors nuclear transcription factor Y (NF-Y), specificity protein 1
(Sp1), and E2 factor 1 (E2F1) (Clem et al., 2003; Zhou et al., 2009). NF-Y is
composed of three subunits, including NF-YA, NF-YB, and NF-YC. The NF-Y
complex binds to CCAAT sequences at gene promoter regions. The CCAAT region
was discovered to be over-represented in cancer-associated genes (Dolfini and
Mantovani, 2013) and thus NF-Y is an important regulator of cancer development.
All three subunits are required for NF-Y function, and NF-YA is the regulatory
subunit. NF-YA contains the DNA-binding region and is overexpressed in breast
carcinoma (Dolfini et al., 2019), gastric adenocarcinoma (Gallo et al, 2021),
cervical cancer (Yang et al., 2020), and lung squamous cell carcinoma (Bezzecchi
et al., 2019). Furthermore, Priest et al. (2021) found YB and YC to be in excess
while NF-YA is the limiting subunit. Thus, we focus on NF-YA as the sensitive
marker for NF-Y complex. Sp1 binds to CG-rich binding sites and mediates cell
growth, differentiation, angiogenesis, and tumorigenesis, and has been implicated
in multiple cancers, including lung cancer (Vellingiri et al., 2020; Vizcaino et al.,
2015; Wang et al., 2003; Hsu et al., 2012). Both NF-Y and Sp1 are required for
securin expression (Zhou et al., 2003). Mutation of either Sp1 or NF-YA binding
sites caused 70% and 25% loss in promoter activity, respectively, while mutation
of both sites caused 90% reduction in promoter activity (Clem et al., 2003). E2F
proteins are overexpressed in tumor cells and contribute to cancer progression
(Yan et al., 2014). E2F1 was the first-discovered E2F transcription factor. It
activates gene transcription and is modified by Cr(VI) exposure (Speer et al.,
2021). E2F1 binds to the PTTG1 promoter region, causing securin induction (Zhou
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et al., 2009). We consider the potential of Cr(VI) to alter NF-YA, Sp1, and E2F1
levels to reduce securin expression.
In addition to DNA-binding elements that promote securin transcription,
there are repressive transcription factors as well. Securin transcription is repressed
by p53 and Kruppel-like factor 6 (KLF6). The p53 protein is a well-known tumor
suppressor that alters gene regulation, and its function is central to carcinogenesis.
p53 inhibits NF-Y binding to the securin promoter, thereby reducing securin protein
expression (Bernal et al., 2002; Hamid et al., 2004; Zhou et al., 2003). KLF6 is a
repressive transcription factor with a binding site in the securin promoter region
that directly inhibits securin transcription (Chen et al., 2013; Lee et al., 2010). Lee
at al. (2010) identified securin as the most upregulated gene in the KLF6(+/-)
mouse liver compared with control samples and showed KLF6 overexpression
reduces securin promoter activity. Chen et al. (2013) showed KLF6 interacts with
the securin promoter and KLF6 knockdown released securin repression. We
evaluated p53 activation and KLF6 protein levels as potential events that lead to
securin downregulation after Cr(VI) exposure.
An alternative hypothesis is securin mRNA loss is a post-transcriptional
event. MicroRNAs (miRNAs) are small (21-25 nucleotides), non-coding RNA
molecules that regulate mRNA translation (Pasquinelli and Ruvkun, 2002).
MiRNAs bind to partial sequence matches of mRNAs and either impede their
translation or induce their degradation (Lee et al., 1993; Wightman et al., 1993;
Bartel, 2004). They are increasingly recognized for their roles in cancer, including
gene regulation, potential cancer biomarkers, and potential therapeutic benefit
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(Macfarlane et al., 2010; Hata et al., 2015; Borralho et al., 2011; Hayes et al.,
2014). Environmental chemicals, including carcinogenic metals, have been shown
to alter miRNAs (Wu et al., 2019; Hu et al., 2011; Humphries et al., 2016). He et
al. (2013) found Cr(VI)-transformed epithelial lung cells highly expressed miR-143,
whose suppression inhibited Cr(VI)-induced transformation and angiogenesis.
Securin-targeting miRNAs have been confirmed and shown to affect proliferation
and migration in pituitary tumor cells (Liang et al., 2015). However, it is unknown if
Cr(VI) exposure specifically alters securin-targeting miRNAs. Therefore, we
investigated Cr(VI)-induced effects on miRNA regulation and potential targeting of
centrosome-associated genes.

RESULTS
Cr(VI) increases nuclear levels of NF-YA and Sp1.
Human lung cells were treated with 0, 0.1, 0.2, and 0.3 ug/cm2 zinc
chromate for 24 and 120 h. Whole cell lysates were probed for the transcription
factor subunit NF-YA. No change in protein expression was observed at any tested
concentration after 24 h or 120 h (Figure 16). In addition to altering protein levels,
Cr(VI) can cause changes in subcellular protein localization. Speer et al. (2021)
showed Cr(VI) exposure causes cytoplasmic accumulation of the homologous
repair protein RAD51, which prevents it from proper intranuclear function.
Transcription factors must be abundant specifically in the nucleus to have their
gene-regulatory effect. Thus, we measured protein levels of NF-YA in nuclear
extracts from human lung cells after 24 h and 120 h of zinc chromate exposure.

88

After 24 h exposure to 0.1, 0.2, and 0.3 ug/cm2 zinc chromate, NF-YA levels
increased to 120.3%, 135.6%, and 142.5% compared with untreated cells,
respectively. 120 h exposure induced increases to 162.6%, 261.4%, and 419.3%
increase, respectively (Figure 17).
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Figure 16. Whole cell NF-YA protein levels in human lung cells after zinc chromate
exposure. This figure shows Cr(VI) exposure did not alter NF-YA whole cell protein
levels. (A) Representative western blot for NF-YA. Alpha-tubulin was used as a
loading control. (B) NF-YA whole cell protein levels were unchanged at any
concentration or timepoint. Data are expressed as percent of untreated control
cells and reflect the mean of three independent experiments. Error bars = SEM.
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Figure 17. Nuclear and cytoplasmic NF-YA protein levels in human lung cells after
zinc chromate exposure. This figure shows Cr(VI) exposure increased NF-YA
nuclear protein levels after prolonged exposure. (A) Representative western blot
for NF-YA. Alpha-tubulin was used as a loading control in cytosolic fractions. Lamin
B1 was used as a loading control in nuclear fractions. (B) NF-YA nuclear protein
levels increased slightly after 24 h Cr(VI). (C) NF-YA nuclear protein levels
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increased after 120 h Cr(VI). (D) Changes in NF-YA nuclear levels were more
apparent after 120 h exposure. Data are expressed as percent of untreated control
cells and reflect the mean of three independent experiments. Error bars = SEM.
No results were significantly different from untreated control groups.
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Sp1 protein levels measured in whole cell protein did not significantly
change after zinc chromate exposure (Figure 18), however 120 h exposure caused
a trend of Sp1 decrease which was dose dependent. To measure Sp1 nuclear
localization, we extracted nuclear protein fractions after Cr(VI) exposure and
analyzed them using western blot. Sp1 nuclear levels after 24 h exposures were
62.5%, 84.4%, and 90.7%, and increased after 120 h to 233.2%, 247.3%, and
403% above control levels, respectively (Figure 19). Together these data show
Cr(VI) causes nuclear levels of NF-YA and Sp1 to increase after acute and
prolonged exposures.
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Figure 18. Whole cell Sp1 protein levels in human lung cells after zinc chromate
exposure. This figure shows Cr(VI) exposure did not significantly alter Sp1 whole
cell protein levels, though 120 h exposure induced a trend towards decreasing
Sp1. (A) Representative western blot for Sp1. Alpha-tubulin was used as a loading
control. (B) Sp1 whole cell protein levels nonsignificantly reduced after 120 h zinc
chromate. Data are expressed as percent of untreated control cells and reflect the
mean of three independent experiments. Error bars = SEM.
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Figure 19. Nuclear Sp1 protein levels in human lung cells after zinc chromate
exposure. This figure shows Cr(VI) exposure increased Sp1 nuclear protein levels
after prolonged exposure. (A) Representative western blot for Sp1. Lamin B1 was
used as a loading control in nuclear fractions. (B) Sp1 nuclear protein levels
increased after 120 h Cr(VI). Data are expressed as percent of untreated control
cells and reflect the mean of three independent experiments. Error bars = SEM.
No results were significantly different from untreated control groups.
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Acute Cr(VI) exposure with NF-YA or Sp1 knockdown
does not cause securin loss.
To help elucidate the potential roles of NF-YA and Sp1 in Cr(VI)-treated
cells, we used siRNAs to separately knockdown each transcription factor. If NFYA or Sp1 plays a role in Cr(VI)-induced securin loss, we expect 48 h knockdown
accompanied by 24 h zinc chromate exposure to cause securin loss similar to 120
h zinc chromate exposure seen in Aim 1. Securin levels increased slightly after 24
h of zinc chromate exposure in each transfection condition, in agreement with 24
h 0.2 µg/cm2 exposure in Aim 1 (Figure 20). Non-targeting siRNA cells had securin
levels of 93% compared with untransfected cells. NF-YA knockdown did not
decrease securin levels significantly, with 86% of control cells. Sp1 knockdown
alone decreased securin to 67% of the control cells, but 24 h zinc chromate
exposure again slightly increased securin levels. Together these data indicate
Cr(VI) does not target securin via the NF-YA and Sp1 proteins.
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Figure 20. Securin protein levels after transcription factor knockdown and acute
zinc chromate exposure. This figure shows 24 h Cr(VI) did not enhance securin
protein loss with transcription factor knockdown. (A) Representative western blot
for securin. Alpha-tubulin was used as a loading control. (B) Securin levels were
not markedly decreased by NF-YA or Sp1 knockdown and 24 h Cr(VI). Data are
expressed as percent of untransfected control cells and reflect the mean of two
independent experiments. Error bars = SEM. No results were significantly different
from untreated control groups.
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E2F1 knockdown does not induce securin loss after acute Cr(VI) exposure.
E2F1 is a securin promoting transcription factor (Zhou et al., 2009) and we
previously published Cr(VI) decreases E2F1 protein and mRNA levels in human
lung cells at prolonged exposure times (Speer et al., 2021). E2F1 loss was not
observed after 24 h Cr(VI) exposure, in agreement with retention of securin after
acute exposure. To determine if securin loss is caused by E2F1 reduction, we
transfected human lung cells with E2F1-targeting siRNAs, along with zinc
chromate exposure. If E2F1 plays a role in Cr(VI)-induced securin loss, we expect
48 h siE2F1 knockdown accompanied by 24 h zinc chromate exposure to cause
securin loss similar to 120 h zinc chromate exposure. Securin levels increased
slightly after 24 h zinc chromate exposure in each transfection condition, as
observed with 24 h 0.2 µg/cm2 exposure in Aim 1 (Figure 21). Non-targeting siRNA
decreased securin levels to 71% compared with untransfected cells, indicating a
potential effect of the transfection process or a potential off-target effect of our nontargeting siRNA. Comparing E2F1 knockdown by two different siRNAs to the nontargeting siRNA, there was no significant change in securin levels. Thus, Cr(VI)induced E2F1 depression does not explain securin loss.
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Does E2F1 Knockdown Affect Securin Protein?
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Figure 21. Securin protein levels after E2F1 knockdown and acute zinc chromate
exposure. This figure shows E2F1 factor knockdown did not recapitulate 120 h
securin loss with 24 h Cr(VI) exposure. (A) Representative western blot for securin.
Alpha-tubulin was used as a loading control. (B) Securin levels were not markedly
decreased by E2F1 knockdown with 24 h Cr(VI). Data are expressed as percent
of untransfected control cells and reflect the mean of two independent
experiments. Error bars = SEM. Significantly different from untransfected control
group (p < 0.05).
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Cr(VI) does not induce securin transcription repressors, p53 and KLF6.
Securin is a target of the tumor suppressor protein p53. p53 interacts
directly with securin and inhibits its transcription (Bernal et al., 2002; Zhou et al.,
2003; Yu et al., 2000). DNA-damaging agents cause p53 phosphorylation at serine
15 (Ser15), which stabilizes the protein and is indicative of p53 activation (Saito et
al., 2003; Zhao et al., 2008). We measured levels of p53 and phospho-p53(Ser15).
p53 activation is assessed by the ratio of phospho-p53/pan-p53 levels. No
significant alterations of p53 whole cell levels or levels of phosphorylated p53 were
observed (Figure 22B-C). Exposure for 120 h did not significantly increase
phosphorylated/pan-p53 ratio (Figure 22D). Overall, Cr(VI)-induced securin loss is
not explained by effects on p53.
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Figure 22. p53 protein levels after zinc chromate exposure. This figure shows
Cr(VI) did not significantly alter p53 levels or phosphorylation status. (A)
Representative western blot for p53. GAPDH was used as a loading control. (B)
Pan-p53 levels (C) phosphor-p53 (Ser15) levels were not significantly changed by
Cr(VI). (D) The ratio of pan-p53/phospho-p53 did not indicate activation by Cr(VI)
exposure. Data are expressed as percent of untransfected control cells and reflect
the mean of two independent experiments. Error bars = SEM. No result was
significantly different from control group.
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KLF6 is a transcription factor, often dysregulated in cancers (Narla et al.,
2001; Reeves et al., 2004), which acts at the securin promoter site to repress its
transcription (Lee at al., 2010; Chen et al., 2013). Increased KLF6 levels in Cr(VI)exposed cells could help explain loss of securin expression. Thus, we measured
nuclear KLF6 protein levels in human lung cells. 24 h exposure did not change
KLF6 nuclear levels, but 120 h exposure to 0.2 and 0.3 ug/cm2 zinc chromate
increased KLF6 to 160% and 240% of control levels, respectively (Figure 23),
which supports the hypothesis Cr(VI) causes securin loss via transcription factor
regulation.
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Figure 23. KLF6 nuclear protein levels after zinc chromate exposure. This figure
shows KLF6 nuclear levels increased after prolonged Cr(VI) exposure. (A)
Representative western blot for KLF6. Lamin B1 was used as a loading control.
(B) KLF6 protein levels increased in the nucleus after 120 h Cr(VI). Data are
expressed as percent of untreated control levels and reflect the mean of three
independent experiments. Error bars = SEM. Significantly different from control
group (p < 0.05).
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Cr(VI) alters miRNA expression
Environmental chemicals, including carcinogenic metals, have been shown
to alter miRNA regulation and play a role in carcinogenesis. To determine how
Cr(VI) influences miRNA expression, we performed miRNA sequencing (miRNAseq) after 24 h, 72 h, and 120 h exposures to 0, 0.1, 0.2, and 0.3 ug/cm2 zinc
chromate. In total, 958 miRNAs were identified and analyzed. MiRNA reads were
compared relative to untreated control cells at each exposure time. At all tested
time points and Cr(VI) concentrations, significantly up- and down-regulated
miRNAs were identified (p < 0.01) (Table 1). At each time point the number of
differentially expressed miRNAs increased with Cr(VI) concentration, with the
exception of 24 h samples, which showed high numbers of both up- and downregulated miRNAs in the 0.2 ug/cm2 zinc chromate condition. With each zinc
chromate concentration, miRNA alteration increased with prolonged exposure
time, except for a peak at the 0.2 ug/cm2 zinc chromate 24 h exposure. This study
was the first to measure Cr(VI)-induced global miRNA expression changes in
human lung cells (Speer at el., 2022).
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24h
Zinc Chromate
Concentration
0.1 0.2 0.3
(ug/cm²)
Total upregulated
23 154
65
Total downregulated 15 55
47
Total altered
38 209 112

72h
0.1
19
70
89

120h

0.2

0.3

0.1

0.2

0.3

19
100
119

55
35
52
54
107 110 123 138
162 145 175 192

Table 1. Significantly up-regulated and down-regulated miRNAs after 24 h, 72 h,
and 120 h zinc chromate exposures (adjusted p-value < 0.01). This table show the
number of significantly altered miRNAs at each timepoint and concentration of
Cr(VI). Data represent the mean of three independent experiments and four
technical replicates.
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To determine if Cr(VI)-induced securin mRNA decrease can be explained
by miRNA interaction, we investigated several securin-targeting miRNAs. A “target
gene to miRNA” search was performed in the miRSystem database (Lu et al.,
2012) and returned six predicted securin-targeting miRNAs (miR-186, miR-655,
miR-105, miR-19b, miR-300, and miR-495). In addition, Liang et al. (2015)
confirmed securin targeting by miR-329 and miR-381. We searched our miRNAseq data for these eight miRNAs. They appeared as significantly altered in only
three of our test conditions as apparently isolated incidents. No miRNA was
consistently altered by zinc chromate. After 24 h, miR-186 and miR-655 were
upregulated with 0.3 µg/cm2 exposure and miR-381 was upregulated with 0.2
µg/cm2 exposure. None of the eight miRNAs were significantly altered after 72 h.
After 120 h, miR-186 was downregulated by 0.3 µg/cm2 exposure.
Although securin-targeting miRNAs were not altered by Cr(VI), miRNAs
could potentially impact other genes in pathways of centrosome regulation and
contribute to centrosome amplification. Centrosome pathways can be found within
the family of chromosome-associated genes in the KEGG BRITE database
hierarchies, which classifies genes based on biological function. Using KEGG
BRITE hierarchies combined with relevant publications, we identified 37 genes
across 7 functional categories, including centriole biogenesis, centriole
disengagement, securin degradation, microtubule nucleation, centriole maturation,
extra centrosome monitoring, and securin transcription factors. For each gene of
interest, we used miRSystem to create lists of potential gene-targeting miRNAs.
Our miRNA-seq data were then searched for all identified miRNAs. To evaluate
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potential gene targeting, any miRNAs that were consistently up- or down-regulated
at all three zinc chromate concentrations within the same time point were counted.
Table 2 shows the numbers of differentially expressed miRNAs predicted to target
each gene. Putative miRNA interactions increased with higher concentrations and
longer exposure times. These data indicate miRNAs may play roles in Cr(VI)
effects on centrosomes. Many of the altered miRNAs were altered at both 72 h
and 120 h, and several were observed to target multiple genes in our list.
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Centriole Biogenesis
Target gene
up 24 h down 24 up 72 h down 72
Plk4
0
0
0
1
SAS6
0
1
0
20
STIL
1
2
3
12
CPAP/CENPJ
0
0
0
1
CEP135
0
3
1
25
CEP152
0
1
0
9
CEP192
0
0
0
3
Centriole Disengagement
Target gene
up 24 h down 24 up 72 h down 72
PLK1
0
0
0
1
PCNT
1
2
5
26
ESPL1
0
0
1
0
PTTG1
0
0
0
0
RAD21
1
0
2
5
CDK1
1
0
0
3
CCNB1
0
2
0
5
Securin Degradation
Target gene
up 24 h down 24 up 72 h down 72
Cdh1
0
1
1
11
UBB
0
0
0
0
UBA52
0
0
0
0
UBC
0
1
0
12
RPS27A
0
0
0
0
APC3/CDC27
0
1
0
5
ANAPC7
0
0
0
5
PP2A/PPP2CA
1
1
0
19
SKP1
1
2
1
13
Cul1
0
1
1
15
FBXO5
0
1
0
4
FBXO43
0
0
0
3
Emi1
0
1
0
4
Microtubule Nucleation
Target gene
up 24 h down 24 up 72 h down 72
NLP
0
1
1
3
Centriole Maturation
Target gene
up 24 h down 24 up 72 h down 72
AURKA
1
0
1
9
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up 120 h down 120
0
3
2
28
3
12
0
2
7
31
1
11
1
3
up 120 h down 120
0
2
7
41
3
0
0
0
1
14
1
7
0
8
up 120 h down 120
6
18
1
0
1
0
0
12
0
0
1
13
0
7
1
29
3
23
2
18
0
5
0
5
0
5
up 120 h down 120
1
4
up 120 h down 120
1
11

Target gene
LATS2
p53
Target gene
Sp1
NF-YA
NF-YB
NF-YC
E2F1
KLF6

Extra Centrosome Monitoring
up 24 h down 24 up 72 h down 72 up 120 h down 120
0
1
1
23
2
30
1
2
1
17
5
26
Securin Transcription Factors
up 24 h down 24 up 72 h down 72 up 120 h down 120
1
5
3
44
15
62
0
3
2
30
3
34
1
1
2
28
4
41
0
0
1
10
1
15
0
2
1
19
4
23
0
2
2
13
4
20

Table 2. This table shows the number of putative targeting miRNAs that are
significantly (adj p-value ≤ 0.01) up- and down-regulated by zinc chromate at each
timepoint and exposure concentration. miRNAs were identified by miRSystem and
searched within our miRNA-seq data. Data represent the number of unique
miRNAs that were significantly altered and potential target each gene of interest.
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Summary
Gene regulation is frequently altered in cancer and represents a known
effect of Cr(VI) exposure, contributing to its carcinogenic mechanism (Raja et al.,
2008; Zablon et al., 2019). While Cr(VI) can broadly alter gene transcription, its
effect specifically on securin transcription is unknown. We investigated three
promoters of securin transcription, NF-YA, Sp1, and E2F1 for their roles in Cr(VI)induced securin loss. NF-YA and Sp1 are the two main transcription factors of
securin and loss of either one decreases securin promoter activity (Clem et al.,
2003). Our study tested the hypothesis that Cr(VI) decreases securin transcription
promoters. Cr(VI) exposure did not significantly change whole cell protein levels of
either NY-YA or Sp1. Measuring nuclear levels, we found both promoters
increased in nuclear fractions at prolonged time points in a concentrationdependent manner. We observed a strong response in nuclear localization after
120 h exposure and thus these promoters are not only present, but apparently
activated upon Cr(VI) and does not explain the securin loss we observed.
We also used siRNA knockdown of NF-YA or Sp1 in combination with 24 h
zinc chromate exposure in an attempt to mimic the 120 h phenotype. If
transcription promoter loss was central to Cr(VI)-induced protein loss, we would
expect premature knockdown to shift the response earlier. However, as reported
in Aim 1, 24 h zinc chromate exposure increased securin levels compared with
unexposed cells. NF-YA knockdown validation was not confirmed by western blot,
so it may require more than 48 h transfection time for levels to decrease, or the
mRNA may not have been appropriately targeted by the siRNA. Sp1 siRNA
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induced the greatest decrease in securin protein. However, 24 h Cr(VI) exposure
with Sp1 knockdown produced a slight increase in securin, indicating a possible
compensatory response to 24 h Cr(VI) exposure that is retained despite gene
knockdown.
We previously reported Cr(VI) inhibits E2F1, which is also a securinpromoting transcription factor. 48 h E2F1 knockdown with 24 h zinc chromate
exposure did not significantly reduce securin levels. Zhou et al. (2009) reported
E2F1 knockdown decreased securin only in p53-deficient cells, and not in p53competent cells. 24 h and 120 h Cr(VI) exposures did not induce p53 loss, so our
results are consistent with previous evidence that E2F1 modification of securin is
p53-dependent.
Our conclusion is Cr(VI) does not target securin by reducing protein levels
or nuclear localization of promoting transcription factors. This does not necessarily
mean securin is not targeted at the transcriptional level. It is possible transcription
factors are prevented from binding to the promoter. Cr(VI) and Cr(III) complexes
have been reported to both activate and repress nuclear binding of transcription
factors, including Sp1 (Raja et al., 2008; Kaltreider et al., 1999). Changes in DNA
methylation could also prevent access to promoter regions (Lou et al., 2003).
Another path to transcription inhibition involves repressive transcription
factors. We measured p53 and KLF6, as they are reported to reduce securin
transcription. We did not measure significantly increased p53 levels after Cr(VI)
exposure. Although Cr(VI) has been reported to activate p53 in cell culture and
elevated p53 protein has been measured in Cr(VI)-exposed workers (Ye et al.,
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1999; Hanaoka et al., 1997), limited or borderline p53 activation has been
observed in lung cells (Luczak et al., 2019) and rat lung (D’Agostini et al., 2002).
Out studies confirm p53 is not a major target of Cr(VI). We measured p53 activation
by the relative phosphorylation of Ser15. Ser15 is phosphorylated upon DNA
damage detection (Saito et al., 2003; Zhao et al., 2008), but activation of p53 is
complex. Multiple post-translational modifications interact to modulate p53
activation, interaction, and stabilization (Lavin et al., 2006). A complete
assessment of the role of Cr(VI)-induced p53 interaction with securin would require
measurements of more subtle combinations of p53 modifications. KLF6 nuclear
levels were increased after 120 h Cr(VI) exposure, which may explain securin loss.
KLF6 knockdown, as was performed with NF-YA, Sp1, and E2F1, would help
clarify the role of Cr(VI) altered KLF6.
Finally, we explored the alternate hypothesis securin loss occurs by a posttranslational mechanism. MiRNAs are altered by environmental chemicals,
including Cr(VI) and other metals (Wu et al., 2019; Hu et al., 2011; Humphries et
al., 2016; He et al., 2013; Liang et al., 2015). However, previous studies only
investigated selected Cr(VI)-altered miRNAs. In this Aim we show zinc chromate
caused global alterations in miRNA levels at all tested concentrations and time
points, as measured by miRNA-seq. We queried miRSystem to identify miRNAs
that provide predicted targeting for several genes of interest. Securin-targeting
miRNAs were not significantly changed according to our data, but several other
genes related to centrosome regulation are potentially affected. Of note, all the
identified transcription factors, Sp1, NY-Y subunits, E2F1 and KLF6, had relatively
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high numbers of putative miRNAs that were down-regulated. MiRNAs typically
repress gene transcription and thus miRNA down-regulation could potentially
contribute to increased NF-YA and Sp1 levels we observed. However, decreased
E2F1 levels after prolonged Cr(VI) (Speer et al., 2021) can not be explained in light
of several positive hits on potential miRNA associations noted here. Proteins
involved in securin degradation, PP2A, SKP1, and Cul1, are also potential miRNA
targets. Upregulation of these proteins by miRNA down-regulation would be
expected to cause increased securin and cyclin B1 degradation. Our data showed
securin degradation was not significantly changed after prolonged Cr(VI).
Investigating premature upregulation by the ubiquitination pathway as a means to
decrease cyclin B1 would be informative.
This Aim shows Cr(VI) disruption of securin and other proteins relevant to
centrosome function and chromosome stability may occur by multi-pronged and
complex mechanisms. Cr(VI) effects may not be explained or recapitulated by
isolated events. A combination of effects on transcription factor function, protein
localization, and miRNAs should be explored in tandem to reveal the mechanisms
of Cr(VI) carcinogenesis in finer detail.
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AIM 3: WHALE CELLS RESIST HEXAVALENT CHROMIUM-INDUCED
SECURIN DISRUPTION AND NUMERICAL CHROMOSOME INSTABILITY

BACKGROUND
According to the multistage theory of carcinogenesis, accumulation of
detrimental and inheritable molecular events in a single cell can develop into
cancer (Nunney, 2016). The likelihood of a cell accumulating the requisite amount
of aberrant changes leading to cancer increases with cell number and time
(Nordling, 1952). Thus, large species would be expected to have higher rates of
cancer and long-lived animals, with more time to accumulate mutations and longer
exposure periods to environmental carcinogens, would be expected to have
greater rates of cancer than species with small bodies and shorter lifespans.
However, these principles do not hold up to observation, an incongruity known as
“Peto’s Paradox” (Nunney, 1999; Caulin and Mauley, 2011; Peto et al., 1975; Peto,
1977). Whales, having 1000-fold the number of cells humans have, would be
expected to have higher rates of cancer than humans. Yet, sperm whales live 6070 years and bowhead whales have been estimated to live over 200 years (Keane,
2015) and reports of cetacean cancers are rare (Newman and Smith, 2006).
In this Aim we use sperm whale and bowhead whale cells as comparative
toxicological models. Sperm whales have the distinction of being deep divers.
Unlike baleen whales that feed mostly at surface, sperm whales hunt at depths of
1000 meters and have been recorded at depths over 2000 meters (Watkins et al.,
2002; Zimmer et al., 2003). They typically remain submerged for 45 minutes and

114

can hold their breath for longer than 90 minutes (Watkins et al., 2002; Watwood et
al., 2006). Reports of chromium speciation in oceans has found that Cr(VI)
concentrations increase in deep waters (Geisler, 1992) and thermal vents emit
heavy metals, making the deep ocean an interesting place to study metal toxicity.
The bowhead whale is one of the largest whale species and with estimated
lifespans over 200 years it is suspected to be the longest living mammal (Keane
et al., 2015). Bowhead whale genome sequencing and comparative analysis
shows gene duplication and loss in genes associated with DNA repair, cell cycle
regulation, cancer, and aging (Keane et al., 2015). Greater understanding of how
whales maintain genomic stability can advance prevention and treatment of human
cancers.
Whales are exposed to environmental carcinogens, such as hexavalent
chromium. Cr(VI) is the dominant speciation of chromium in sea water (Geisler and
Schmidt, 1992) and whale skin sampling show high levels of chromium
accumulation. Sperm whales sampled across the globe had 0.9 to 122.6 µg Cr/g
tissue with a global mean of 8.8 µg/g (Wise et al., 2009), North Atlantic right whales
had mean Cr levels of 7.1 µg/g tissue (Wise et al., 2008), and fin whales sampled
from the Gulf of Maine showed Cr levels of 1.71 to 19.6 µg/g. These levels are
high compared to data on non-occupational human chromium accumulation of
0.31 µg/g (Schroeder et al., 1970) and occupation-associated Cr-induced lung
cancer accumulation levels of 0.4-132 µg/g with a mean of 20.4 µg/g (Tsuneta et
al., 1980). Elevated levels of environmental carcinogens could pose health risks to
exposed wildlife, and indeed studies find the St. Lawrence Estuary population of
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beluga whales have high cancer rates, likely due to contamination by
organochlorines, polycyclic aromatic hydrocarbons, and heavy metals (Newman
and Smith, 2006; Martineau et al., 2002; De Guise et al., 1994). Reports of high Cr
levels in whale biopsies inspired toxicological investigations of Cr(VI) in whales.
Soluble and particulate chromates induced cytotoxicity and genotoxicity in North
Atlantic right whale lung and testes fibroblasts (Wise et al., 2008; Li Chen et al.,
2009). Cell culture studies confirmed Cr(VI)-induced cytotoxicity and genotoxicity
in sperm whale (Wise et al., 2001), and fin whale cells as well (Wise et al., 2015).
Measurements of cytotoxicity and genotoxicity in whale cells however were
lower than those of Cr(VI)-exposed human cells (Li Chen et al., 2009; Li Chen et
al., 2012.). Li Chen et al. (2009) compared cytotoxicity of particulate lead chromate
in human and North Atlantic right whale lung cells. Whale lung cells had
significantly higher survival rates than human lung cells at the same administered
concentrations. Structural chromosome damage was significantly higher in human
cells than in whale cells. Intracellular chromium levels were higher in humans, but
even after correcting for uptake, human cells still had significantly higher rates of
damage than whale cells. Similarly, when comparing human and sperm whale skin
cells, whale cells had higher survival rates and lower chromosome damage than
human cells (Li Chen et al., 2012). These data show whale cell resistance to Cr(VI)
toxicity is not organ-specific and is observed in both baleen whale and toothed
whale species, which occupy distinct trophic categories.
In the effort to discover how whale cells resist Cr(VI)-induced genotoxicity,
molecular investigations revealed important species-specific differences in DNA
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repair response. Browning et al. (2017) showed homologous recombination repair,
the mechanism that corrects DNA double strand breaks incurred by Cr(VI), was
retained in North Atlantic right whale cells after Cr(VI) exposure. This outcome is
in stark contrast to the earlier finding Cr(VI) induces loss of homologous
recombination repair in human cells (Browning et al., 2016; Qin et al., 2014).
Transcriptome analysis from whale cells exposed to Cr(VI) show upregulation of
DNA repair pathways at moderate exposure levels and induction of apoptosis
pathways at highest exposure levels (Pabuwal et al., 2013).
Comparisons of whale and human molecular responses to Cr(VI) shed light
on key events in the carcinogenic pathway. Previous studies reveal how whale
cells avoid structural chromosome instability (Browning et al., 2017), however, no
studies have explored numerical CIN in whale cells. Numerical chromosome
instability is a hallmark of cancer and observed in the majority of solid tumors
(Tweats et al., 2019; Farkas et al., 2016; Duijf and Benezra, 2013). Numerical
chromosome instability and centrosome amplification are key effects of Cr(VI)
exposure (Martino et al., 2015; Holmes et al., 2010; Holmes et al., 2006) and in
Aim 1 we show centrosome regulation disruption, including securin protein loss,
underpins these effects. Here we translate our Aim 1 findings of Cr(VI)-induced
centrosome dysregulation in human cells to whale cells, and for the first time
characterize centrosome effects and numerical chromosome instability in whale
cells.
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RESULTS
Particulate hexavalent chromium is cytotoxic to whale cells.
After 24 h of zinc chromate treatment at 0.1, 0.15, 0.2, 0.3, and 0.4 µg/cm2,
sperm whale skin fibroblasts produced colony numbers 89.3%, 80.8%, 70.3%,
66.3%, and 51.1% relative to untreated cells (Figure 24A). After 120 h of treatment
at the same concentrations, relative survival was 85.2%, 80.9%, 64.7%, 47.6%,
and 19.6% respectively. Survival was statistically less than controls at 0.2, 0.3 and
0.4 µg/cm2 for both time points. After 24 h of zinc chromate treatment at 0.1, 0.15,
0.2, 0.3, and 0.4 µg/cm2, bowhead whale lung fibroblasts produced colonies at
96.7%, 92.5%, 90.3%, 86.8% and 79.3% relative to untreated cells (Figure 24B),
with the highest concentration producing significantly different results compared to
control. Relative survival after 120 h of exposure was similar to 24 h exposures at
94.1%, 90.2%, 80.6%, 79.3%, and 79.5%. The difference compared to control was
significant for 0.2, 0.3 and 0.4 µg/cm2 zinc chromate treatments. Sperm whale and
bowhead whale cells show different responses to prolonged Cr(VI) exposure.
While survival after 120 h decreased in sperm whale cells, survival rates for
bowhead whale cells were not significantly less than after 24 h exposures.
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Figure 24. Cr(VI)-induced cytotoxicity in whale cells. This figure shows Cr(VI) is
cytotoxic to sperm whale and bowhead whale cells. (A) Colony survival of sperm
whale cells after 24 h and 120 h zinc chromate treatment, relative to control. (B)
Colony survival of bowhead whale cells after 24 h and 120 h zinc chromate
treatment, relative to control. Data reflects the mean of three independent
experiments. Error bars = SEM. *Significantly different from untreated cells at the
same timepoint (p < 0.05).
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Cr(VI) induces chromosome breaks and cell cycle arrest
in bowhead whale cells.

Cr(VI) causes chromosome damage and cell cycle arrest in human cells
(Xie et al., 2005; Xie et al., 2009), thus we characterized these toxic effects in
bowhead whale cells. Metaphase chromosomes were analyzed for chromosome
aberrations such as breaks and gaps and spreading centromeres (Figure 25). After
24 h exposure to 0.1, 0.15, 0.2, 0.3, and 0.4 µg/cm2 whale lung cells had 10%,
8.7%, 7.7%, 14%, and 17.3% metaphases with at least one damaged
chromosome, while untreated cells had 2.7%. 120 h exposure caused 6.3%, 6.7%,
9.3%, 7%, and 9.7%, of metaphases to exhibit damage, with control cells
measuring 4%. Lower levels of damage after 120 h may be due to cell cycle arrest
of damaged cells.
Changes in cell cycle phase were analyzed by flow cytometry. Analysis of
DNA content shows the proportion of cells that are in each cell phase. 24 h
exposure did not change cell cycle distribution, while 120 h exposure decreased
G1 cell populations slightly and enriched G2/M phase cells, although this change
is not statistically significant (Figure 27). One drawback to using flow cytometry for
cell cycle analysis is G2 and M phases can not be distinguished by DNA content
alone. Mitotic index analysis was performed using light microscopy to determine if
changes in G2 and M phase were occurring (Table 3). Mitotic cell counts show 24
h exposure of 0, 0.1, 0.2, 0.3, and 0.4 µg/cm2 zinc chromate yielded 83, 64.7, 50,
42.3 and 38 mitotic cells per 5000 cells scored. 120 h exposure produced 50.7, 45,
32.3 27.3, and 20.7 mitotic cells per 5000 cells scored. This indicates depression
of mitosis and combined with the flow cytometry data suggest Cr(VI) causes G2
120

cell cycle arrest in bowhead whale cells. These data show zinc chromate causes
cell cycle arrest in bowhead whale cells after 120 exposure.
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Figure 25. Cr(VI)-induced chromosome aberrations in bowhead whale cells. This
figure shows Cr(VI) is caused chromosome damage in bowhead whale cells. Data
reflects the mean of three independent experiments. Error bars = SEM.
*Significantly different from control group (p < 0.05).
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Figure 26. Cell cycle analysis in bowhead whale cells after 24 h and 120 h zinc
chromate exposure. This figure shows Cr(VI) caused a slight decrease in the
percentage of G1 phase bowhead whale cells and a corresponding increase in
G2/M after prolonged exposure. Data reflects the mean of three independent
experiments. Error bars = SEM. No groups were significantly different from control
group.
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Mitotic Index Analysis
24 h
Zinc Chromate
(ug/cm2)
0
0.1
0.2
0.3
0.4

120 h

Average

SEM

Average

SEM

83.0
64.7
50.0
42.3
38.0

4.0
4.4
13.9
5.4
3.1

50.7
45.0
32.3
27.3
20.7

12.7
13.0
11.6
11.9
11.6

Table 3. Mitotic index in bowhead whale cells after 24 h and 120 h zinc chromate
exposure. This table show the number of mitotic cells per 5000 total cells after
Cr(VI) exposure. The mitotic index decreases after acute and prolonged Cr(VI).
Data reflects the mean of three independent experiments.
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Cr(VI) does not induce securin loss in whale cells.

We measured securin levels in bowhead whale cells after 24 and 120 h
exposure to 0.1, 0.2, and 0.3 ug/cm2 zinc chromate (Figure 27). The greatest
reduction in securin levels was observed after 120 h exposure to 0.3 ug/cm2
resulting in 85.6% of untreated control levels, which was not statistically significant.
In Aim 1 we show 120 h exposure to 0.1, 0.2, and 0.3 ug/cm2 zinc chromate causes
securin levels to drop to 48.5%, 31%, and 15.3%, respectively, in human cells.
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Figure 27. Securin protein levels in bowhead whale lung cells after 24 h and 120
h zinc chromate exposure. This figure shows prolonged Cr(VI) exposure did not
alter securin levels in whale cells. (A) Representative western blot for securin.

BHW
N=3 control. (B) Securin whole cell protein levels
Alpha-tubulin was used
as a loading
were unchanged at all concentrations and timepoints. Data are expressed as
percent of untreated control cells and reflect the mean of three independent
experiments. Error bars = SEM. No results were significantly different from control
group.
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Cr(VI) does not induce spindle assembly checkpoint bypass in whale cells.
The retention of securin levels by whale cells after 120 h Cr(VI) is a notable
difference compared to the human cell response. Spindle assembly checkpoint
(SAC) is a mechanism that prevents progression from metaphase to anaphase
until all kinetochores are properly attached to spindle fibers. The SAC is a
protective mechanism against aneuploidy. SAC bypass allows cell division to occur
in conditions of improper kinetochore-microtubule attachments, resulting in lagging
chromosomes at anaphase and asymmetrical chromosome segregation.
Centrosome amplification can cause abnormal mitosis via improper kinetochore
attachments and thus SAC is a protective measure against this disruption. SAC
bypass serves as an indicator of securin dysfunction, as aberrant separase activity
is responsible for cleaving the centromeres before anaphase. Particulate chromate
has been shown to cause SAC bypass in human lung fibroblasts, observed as
centromere spreading, premature centromere division, and premature anaphase
(Holmes et al., 2010; Wise et al., 2006). Definitions of these phenomena are
described in Wise et al. (2006) and followed here. Centromere spreading entails
separation of the chromatids at the centromere only and not the entire length of
the chromosome. Premature centromere division is defined as at least one
chromosome fully dissociated from its sister chromatid, while at least one other
chromosome in the same metaphase is still attached. Premature anaphase is
defined as all chromosomes being completely separated.
Strikingly, sperm whale skin fibroblasts show resistance to particulate
chromate-induced SAC bypass (Figure 28A). All treatments showed zero increase
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in centromere spreading after 24 and 120 h. After 24 and 120 h, premature
centromere division and premature anaphase occurred in 0.3 to 1.0% of
metaphases in a non-dose dependent fashion.
Bowhead whale lung fibroblasts also show resistance to SAC bypass
(Figure 28B). No centromere spreading was observed in any treatment
concentrations after either 24 or 120 h. Premature centromere division occurred in
0.5% of cells after both 24 and 120h at 0.4 µg/cm2 zinc chromate concentration.
Separase is the protein that cleaves cohesin at the centromeres, and thus
SAC bypass and abnormal centromere division is also evidence of aberrant
separase activity. We demonstrate in Aim 1 Cr(VI)-induced securin loss leads to
abnormal separase activity in human lung cells. Lack of SAC bypass in whale cells
indicates normal separase regulation in whale cells even after prolonged Cr(VI)
exposure. In contrast to human cells (Wise et al., 2006) whale cells do not exhibit
Cr(VI)-induced SAC bypass or loss of securin function.
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Figure 28. Spindle assembly checkpoint bypass in whale cells after 24 h and 120
h zinc chromate exposure. This figure shows Cr(VI) does not induce SAC bypass
in whale cells. (A) Sperm whale metaphases do not display centromere spreading,
premature centromere division, or premature anaphase, shown in stacked
columns. (B) Bowhead whale metaphases do not display centromere spreading,
premature centromere division, or premature anaphase, shown in stacked
columns. Data reflect the mean of three independent experiments. † = Fewer than

BHW N=3

100 metaphases were produced for analysis. Error bars = SEM. No results were

SPW N=3 †=fewer than 60
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significantly different from control group.
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Cr(VI) does not induce centrosome amplification in interphase whale cells.
Previous studies show centrosome amplification increases with Cr(VI)
exposure time and concentration and correlates with increased numbers of
aneuploid metaphases in human lung cells (Martino et al., 2015). Centrosome
amplification has been shown to occur in prolonged G2 phase induced by DNA
damage, indicating interphase is when centrosome amplification arises (Dodson
et al., 2004; Holmes et al., 2010; Inanç et al., 2010). To determine if observed DNA
damage and cell cycle arrest in Cr(VI)-exposed whale cells induces centrosome
amplification, we analyzed centrosomes in interphase cells. Centrosomes were
counted in 100 interphase cells per treatment concentration. Bowhead whale
interphase cells (Figure 29A) exposed to 0, 0.2, 0.3, and 0.4 µg/cm2 zinc chromate
for 24 h had 1.5%, 3.5%, 2.0%, and 2.5% centrosome amplification. After 120 h,
percent of centrosome amplification was 2.0%, 0.5%, 6.0% and 4.0%. Sperm
whale interphase cells (Figure 29B) exposed to 0, 0.2, 0.3, and 0.4 µg/cm2 zinc
chromate for 24 h had greater than 2 centrosomes in 2.5%, 2.0%, 3.0% and 3.0%
of cells respectively. After 120 h exposure, sperm whale cells showed 4.5%, 4.5%,
3.5%, and 1.5% centrosome amplification. No treatments showed significant
increase in centrosome amplification in either cell line or exposure time point.
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Figure 29. Centrosome amplification in interphase whale cells after 24 h and 120
h zinc chromate exposure. This figure shows Cr(VI) does not induce centrosome
amplification in interphase whale cells. (A) Bowhead whale cells and (B) Sperm
whale cells do not experience Cr(VI)-induced centrosome amplification. 100 cells
scored per experimental condition. Data reflect the mean of two independent
experiments. Error bars = SEM. No results were significantly different from the
control group.
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Cr(VI) does not induce centrosome amplification in mitotic whale cells.
Rare cells with supernumerary centrosomes may progress to mitosis and
produce aneuploid daughter cells (Brinkley, 2001; Nigg et al., 2014). It is during
mitosis that centrosome amplification can cause chromosomal instability, so we
also analyzed mitotic cells. Centrosomes were counted in 50 mitotic cells per
treatment concentration. After 24 h, an average of 2.19% untreated mitotic
bowhead whale cells (Figure 30A) had centrosome amplification. Treatment with
0.2, 0.3, and 0.4 µg/cm2 zinc chromate produced 3.13%, 3.17%, and 1.52%
centrosome amplification. After 120 h, 2% of untreated mitotic cells had greater
than 2 centrosomes, while treated cells showed centrosome amplification in 0%,
2%, and 2.13% of mitotic cells.
After 24 h, untreated sperm whale cells (Figure 30B) contained greater than
2 centrosomes in 7% of mitotic cells, while 0.2, 0.3, and 0.4 µg/cm2 zinc chromate
treatment produced 5.2%, 1.2% and 0% centrosome amplification. Fewer than 50
mitotic cells were found after 24 h exposures of both 0.3 and 0.4 µg/cm2 zinc
chromate. After 120 h, 2% of untreated mitotic cells had centrosome amplification,
and treatment resulted in 1%, 2%, and 2.9% centrosome amplification. After 120
h fewer than 50 mitotic cells were found in the highest concentration of 0.4 µg/cm2
zinc chromate. No treatments showed significant increase in centrosome
amplification in either cell line or exposure time point.
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Figure 30. Centrosome amplification in mitotic whale cells after 24 h and 120 h
zinc chromate exposure. This figure shows Cr(VI) does not induce centrosome
amplification in mitotic whale cells. (A) Bowhead whale cells and (B) sperm whale
cells do not display Cr(VI)-induced centrosome amplification in mitotic cells. 50
cells scored per experimental condition. Data reflect the mean of two independent
experiments. † = Fewer than 45 mitotic cells present per experiment. ‡ = Fewer
than 25 mitotic cells present per experiment. Error bars = SEM. No results were
significantly different from the control group.
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Whale cells are resistant to Cr(VI)-induced numerical CIN.
Aneuploidy is defined as the loss or gain of entire chromosomes. Numerical
chromosome instability is a dynamic process characterized by changing numbers
of chromosomes. Changes in polidy from the stable chromosome number are
measured as evidence of numerical chromosome instability. Numerical
chromosome instability is a key effect of Cr(VI) in human cells. Exposure of 0.1,
0.15, and 0.2 μg/cm2 zinc chromate for 120 h induced 28%, 40%, and 44%
aneuploid metaphases, respectively, in human lung cells (Holmes et al., 2010). We
analyzed

aneuploidy

in

whale

cells

by

metaphase

analysis,

counting

chromosomes per metaphase and classifying those with greater or fewer than 42
chromosomes as aneuploid. We scored 100 metaphases with 40–44
chromosomes and any hyper- or hypodiploid metaphases were also added to the
aneuploidy analysis. Metaphases were analyzed for aneuploidy after 24 and 120
h of zinc chromate treatment.
For the 24 h time point, bowhead whale control group showed 20.3%
aneuploid metaphases while 0.1, 0.15, 0.2, 0.3, and 0.4 µg/cm2 treatment resulted
in 21.6%, 26.0%, 21.0%, 21.3%, and 22.5% aneuploid metaphases (Figure 31A).
After 120 h, control cells showed 23.2% aneuploid metaphases and treatment
resulted in 23.3%, 22.0%, 30.8%, 25.1%, and 29.0% aneuploid metaphases. None
of the treatment results were significantly different from the control bowhead whale
cells.
Sperm whale control cells from the 24 h treatment group had 13.8%
aneuploid metaphases and 0.1, 0.15, 0.2, 0.3, and 0.4 µg/cm2 treatment resulted
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in 16.5%, 11.5%, 11.9%, 12.3%, and 15.5% aneuploid metaphases, respectively
(Figure 31B). The 120 h control had 12.9% aneuploid metaphases while the
treatments had 10.2%, 17.3%, 12.0%, 18.6%, and 22.6% respectively. The
elevated percentages at the two highest concentrations are in treatments that
failed to produce 100 metaphases in each experiment. The two highest
concentrations, 0.3 and 0.4 µg/cm2 zinc chromate, were significantly different from
the control bowhead whale cells (p = 0.024 and p = 0.012 respectively).
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Figure 31. Percent of aneuploid metaphase in whale cells after 24 h and 120 h zinc
chromate exposure. This figure shows Cr(VI) does not induce aneuploidy in whale
cells. (A) Percent of aneuploid bowhead whale metaphases do not increase with
Cr(VI). (B) Bowhead
PercentWhale
of aneuploid
aneuploidysperm whale metaphase do not increase with
Cr(VI). 100 metaphases scored per experimental condition. Data reflect the mean
Sperm Whale aneuploidy

of three independent experiments. † = Fewer than 100 metaphase present per
experiment. Error bars = SEM. No results were significantly different from the
control group.
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Chromium uptake differs between sperm whale and bowhead whale cells.

The difference in cytotoxicity between sperm whale and bowhead whale
cells may be caused by differences in Cr(VI) uptake by the cells. We measured
intracellular chromium after treatment at all experimental concentrations for 24 and
120 h. These data show that intracellular chromium concentration is higher in
sperm whale cells than bowhead whale cells (Figure 32) after equal
administrations and at both time points. In bowhead whale cells (Figure 32A), 24
h of exposure to 0, 0.1, 0.15, 0.2, 0.3, and 0.4 µg/cm2 zinc chromate administration
caused average intracellular chromium concentrations of 0, 68, 94, 89, 129, and
247 µM. Exposure of 120 h at the same administered concentrations resulted in 0,
78, 107, 159, 278, and 338 µM chromium. In sperm whale cells (Figure 32B), 24 h
of exposure to 0, 0.1, 0.15, 0.2, 0.3, and 0.4 µg/cm2 zinc chromate administration
resulted in average intracellular chromium concentrations of 0, 109, 198, 302, 427,
and 532 µM. Exposure of 120 h at the same administered concentrations resulted
in 0, 101, 195, 323, 404, 862 µM chromium. Comparing intracellular concentrations
between 24 and 120 h exposures did not reveal significant increases for either cell
line.
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Figure 32. Intracellular chromium concentration (µM) in whale cells after 24 and
120 h of zinc chromate exposure. This figure shows intracellular chromium levels
increase after 24 h and 120 h of Cr(VI) exposure. (A) Bowhead whale cells take
up less chromium than (B) sperm whale cells. Data reflect the mean of three
independent experiments. Error bars = SEM. à = Data significantly different
between cell lines (p < 0.05). *Significantly different significantly different from the
control group within the same cell line and timepoint (p < 0.05).

138

SUMMARY

Previous studies demonstrate that prolonged particulate Cr(VI) exposure
causes significant aneuploidy in human lung fibroblasts which correlates with
centrosome amplification (Holmes et al., 2010; Martino et al., 2015). Whales are
long-lived air breathers and are exposed to Cr(VI) (Wise et al., 2015; Wise et al.,
2009), however the rates of cancer in these animals appear to be much lower than
in humans (Caulin & Maley, 2011). Comparative investigations between human
and whale cells revealed that while Cr(VI) is cytotoxic and genotoxic to both
species, whale cells were more resistant to cytotoxicity and to structural
chromosome damage compared to human cells (Li Chen et al., 2012; Li Chen et
al., 2009). However, no previous studies have investigated numerical chromosome
instability or centrosome amplification in whales. Interspecies differences in these
key promoters of carcinogenesis can illuminate the mechanism of Cr(VI)-induced
genomic instability. Here we found, as opposed to human cell responses shown in
Aim 1, Cr(VI) did not induce securin loss and separase dysfunction in whale cells.
In addition, Cr(VI) did not induce aneuploidy or centrosome amplification in whale
cells, which supports our hypothesis securin loss is a central event in Cr(VI)
carcinogenesis.
Cytotoxicity assays show administered concentrations of 0.2, 0.3, and 0.4
µg/cm2 zinc chromate cause statistically significant decreases in colony formation
compared to control in both sperm whale and bowhead whale cell lines after 120
h of exposure. Zinc chromate at these levels was cytotoxic to sperm whale skin
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fibroblasts after 24 h of exposure, whereas bowhead whales showed significant
cytotoxicity after 24 h only at the highest concentration of 0.4 µg/cm2. The
difference in survival between 24 and 120 h was significant in sperm whales at 0.1,
0.2, 0.3, and 0.4 µg/cm2 zinc chromate concentrations, however zinc chromate
was not significantly more toxic to bowhead whale cells after 120 h compared to
24 h at the same concentration. Percent survival relative to control was not
significantly different between cell lines, except at the highest concentration
(Student’s t-test, p > 0.05). At both time points sperm whale cells were more
sensitive to cytotoxicity upon 0.4 µg/cm2 zinc chromate administration.
Relative survival after 24 h shown here are in line with published cytotoxicity
in sperm whale skin fibroblasts after 24 h treatments of similar levels of lead
chromate, another particulate form of Cr(VI) (Wise et al., 2011). At similar
administered concentrations of lead chromate, zinc chromate appears to induce
similar colony reduction in sperm whale cells. Concentrations of 0.1 and 0.5 µg/cm2
lead chromate induce 86 and 63% relative survival (Wise et al., 2011) while 0.1
and 0.4 µg/cm2 zinc chromate induce 89% and 51% relative survival after 24 h.
While sperm whale cell survival decreased after 120 h of exposure,
intracellular chromium concentrations were not significantly increased after 120 h
compared to 24 h for either cell line. Since intracellular chromium levels increase
with administered concentration, it is apparent that the cell is not saturated with
chromium at lower experimental concentrations, and it is expected that with
prolonged exposure time the cell continues to take up chromium, especially as it
is brought out of solution by binding to intracellular molecules. It is possible that
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prolonged exposure to low intracellular chromium causes increased cytotoxicity at
120 h.
Securin is the protein that controls separase activity. In Aim 1 we show
Cr(VI) causes loss of securin in human cells and abnormal separase activity. We
measured securin levels in bowhead whale lung cells and found protein is retained
at normal levels after even 120 h of Cr(VI) exposure. Spindle assembly checkpoint
protects against aneuploidy by preventing progression to anaphase until all
kinetochores are properly attached to spindle fibers. Centromere spreading,
premature centromere division, and premature anaphase are consequences of
particulate Cr(VI) exposure in human lung fibroblasts (Holmes et al., 2010). These
phenotypes produced in metaphase-arrested cells are evidence of spindle
assembly checkpoint bypass. Neither sperm whale nor bowhead whale cells
showed evidence of spindle assembly checkpoint bypass at any treatment
conditions, demonstrating that these whale species somehow maintain regulation
of spindle assembly checkpoint proteins under conditions in which human lung
cells do not. Separase cleaves cohesin at centromeres and thus these data
indicate separase is not prematurely active in metaphase whale cells after Cr(VI)
exposure.
Zinc chromate treatment did not induce centrosome amplification in
bowhead or sperm whale interphase cells at any treatment concentration or time
point. The point at which centrosome amplification becomes critical is during
mitosis, as aberrant segregation of chromosomes results in aneuploidy (Ganem et
al., 2009). Cells can overcome multipolar arrangements by clustering centrosomes
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to form pseudo-bipolar spindle poles (Ganem et al., 2009). However, this coping
mechanism does not ensure faithful chromosome segregation because excess
centrosomes block one another and may also form erroneous kinetochore
attachments before moving into bipolar positions. Normal mitotic cells have 2
centrosomes. During our study, no zinc chromate treatment conditions caused
aberrant centrosomes to elevate above control percentages in either cell line.
Consistent with the metaphase assays, 0.4 µg/cm2 zinc chromate caused
depressed mitotic numbers in sperm whale cells, suggesting cell cycle arrest.
Background levels of centrosome amplification were low in both mitotic and
interphase whale cells.
It is possible that whale cells with centrosome amplification are culled by
apoptosis. However, cytotoxicity data for bowhead whale lung fibroblasts reveal
only mild decreases in relative survival with increasing zinc chromate
concentrations. Mitotic arrest seen at the high end of our experimental
concentrations could be a strategy to prevent aberrant cells from dividing and
producing aneuploid cells, however research has identified G2 arrest to be
causative in centrosome amplification and these data prove that interphase
centrosome amplification does not increase in whale cells exposed to Cr(VI). Thus,
these data suggest that whales have evolved strategies to combat chromosome
instability induced by Cr(VI) which are lacking in human cells.
The mechanisms of centrosome amplification are unknown. Hypotheses
center on protein dysregulations that allow the centrosome duplication cycle to
become desynchronized with cell cycle progression (Agircan et al., 2014; Bolgioni
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& Ganem, 2016; Hatano & Sluder, 2012). The fact that zinc chromate does not
cause centrosome overduplication in whale cells make them a useful comparative
model for studying the molecular components that regulate centrosome
duplication. This result supports the hypothesis whale cells avoid Cr(VI)-induced
centrosome amplification and SAC bypass by retaining sufficient securin protein
Aneuploidy was evaluated after zinc chromate treatment in sperm whale
and bowhead whale cells. Notably, after 120 h of exposure to 0.4 µg/cm2 zinc
chromate, sperm whale cells experienced cell cycle arrest, failing to yield enough
metaphases to analyze. No treatment condition produced aneuploidy in excess of
control cells. Bowhead whale cells had slightly higher background levels of
aneuploidy (20.3%) compared to sperm whale cells (13.8%). Published results
show that 0.1, 0.15, and 0.2 µg/cm2 zinc chromate caused 28%, 40%, and 44%
aneuploidy in human lung cells, which is significantly higher than the background
rates of 8-13% (Holmes et al., 2010). Our current study suggests that whale cells
are resistant to Cr(VI)-induced numerical chromosome instability.
A tempting explanation for how whale cells avoid the consequences of
Cr(VI) exposure that human cells exhibit is that Cr(VI) uptake is less in whale cells.
Indeed, comparative studies show that chromium uptake differs between whale
and human cells. Lead chromate experiments show human cells achieve higher
intracellular concentrations than whale cells after equal administrations. However,
Li Chen et al. (2012) corrected for differential uptake and showed that uptake
differences did not fully explain clastogenic differences such as structural
chromosome damage. While whale cells show extremely low occurrences of
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numerical chromosome instability and centrosome amplification, we do observe
cytotoxicity, cell cycle arrest, and DNA double strand breaks which indicate Cr(VI)
presence in the cell is having many of the same toxic indications as in human cells.
Thus, uptake does not sufficiently explain how whales evade Cr(VI)-induced
centrosome amplification and numerical CIN.
Whale cell resistance to Cr(VI)-induced centrosome amplification and
numerical chromosome instability highlights the important link between these two
phenotypes which are proposed to underlie carcinogenesis. Species comparisons
between human and whales can help to elucidate the molecular mechanisms of
Cr(VI) carcinogenesis and indeed the stark difference in securin protein response
in human cells, illustrated in Aim1, and whale cells, illustrated in Aim 3, support the
hypothesis securin is a key centrosome regulator which is targeted by Cr(VI).
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CHAPTER 4: DISCUSSION

Overview
Lung cancer is by far the deadliest cancer worldwide and resulted in 1.8
million deaths in 2020 (Sung et al., 2021). The most well-known cause of lung
cancer is cigarette smoking, but the World Health Organization estimated up to
25% of deaths occur to patients who never smoked, indicating other causes such
as occupational exposures and air pollution are important contributors (Sung et al.,
2021; Couraud et al., 2012). Hexavalent chromium [Cr(VI)] is a lung carcinogen
with widespread environmental and occupational exposure risks. Despite decades
of study on Cr(VI) in lung cancer through occupational exposures, in vivo animal
studies, and cell culture experiments, its molecular mechanism of carcinogenesis
is not fully understood (Tsuneta et al., 1980; Langård and Vigander, 1983; Levy et
al., 1986; Takahashi et al., 2005; Wise et al., 2002; Xie et al., 2007).The prevailing
theory implicates Cr(VI)-induced chromosomal instability. However, little is known
about how Cr(VI) induces numerical chromosome instability.
Aneuploidy is characterized by loss or gain of whole chromosomes per cell
and it is the most common form of chromosomal instability observed in cancers
(Chan, 2011; Compton, 2011). One proposed mechanism by which numerical
instability arises is through centrosome amplification (Brinkley, 2001; Compton,
2011; D'Assoro et al., 2002; Ganem et al., 2009). Centrosome amplification has
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been observed in a wide range of solid and hematological cancers and has been
identified as an early event in carcinogenesis (Chan, 2011; Wise & Wise, 2010).
Centrosome amplification increases with tumor aggressiveness and correlates
with poor prognoses (Chan, 2011). It is an observed outcome of exposure to
carcinogenic metals such as Cr(VI), cadmium, and arsenic (Holmes et al., 2010;
Zhang et al., 2019; Yi et al., 2006). Thus, centrosome amplification is an important
cancer phenotype as well as a potential key mechanism of metal carcinogenesis.
This dissertation investigates potential mechanisms of centrosome amplification
and numerical chromosome instability after Cr(VI) exposure to build on previous
work that shows these are potential keys to its carcinogenic mechanism.
Securin is an important regulatory protein involved in numerical
chromosome stability and centrosome maintenance (Zhou et al., 1999; Jallepalli
et al., 2001; Chao et al., 2006). DNA-damaging agents have been found to alter
securin levels (Zhou et al., 2003; Zhou et al., 2005) and its role in centrosome
amplification and chromosome instability has been confirmed by gene modulation
experiments (Yu et al., 2003; Zhou et al., 2005; Kim et al., 2007; Tsou and Stearns,
2006; Mora-Santos et al., 2013). Securin dysregulation has been observed in
several cancers (Kakar, 2006). However, no investigations focus on the impact of
Cr(VI) exposure on securin regulation. This dissertation tests the hypothesis Cr(VI)
causes securin disruption, which alters separase activity, and leads to centrosome
amplification and numerical chromosome instability. As a ubiquitous environmental
contaminant, Cr(VI) poses potential threats to wildlife and humans. Thus, we
explore our hypothesis using the One Environmental Health approach. We
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conducted our investigation in three aims showing: 1) Cr(VI) targets securin
causing loss of expression in human lung cells, 2) Cr(VI) alters nuclear levels of
transcription factors and miRNA expression in human lung cells, and 3) whale cells
are resistant to Cr(VI) induced effects observed in human cells.

Prolonged Cr(VI) exposure targets securin, causing loss of protein
levels and function.
In Aim 1 we tested the hypothesis particulate Cr(VI) causes securin
disruption. Securin is a key protein in numerical chromosome stability because 1)
it regulates separase cleavage at centromeres to restrict chromatid division until
proper spindle assembly and anaphase progression and 2) it regulates separase
activity at centrosomes to restrict centrosome duplication to once per cell cycle.
Securin disruption could explain previous reports of Cr(VI)-induced SAC bypass,
premature

centriole

division,

centrosome

amplification,

and

numerical

chromosome instability (Wise et al., 2006; Holmes et al., 2010; Martino et al.,
2015).
The first step to investigating the effects of Cr(VI) on securin was to
measure protein levels. After 24 h exposure, securin protein levels showed a trend
toward increased levels with Cr(VI) concentration which was not statistically
significant, but levels significantly decreased after 120 h. Despite known securin
involvement in chromosome instability and carcinogenesis, the role of securin in
carcinogenic metal exposure is not well known. Chao et al. (2006) showed 24 h
arsenite treatment suppressed securin expression in both mouse endothelial cells

147

and human colorectal epithelial cancer cells. It is possible securin is abundant in
human lung cells and the remaining protein is sufficient to control separase activity.
It is also possible the cell could respond to securin loss with compensatory
regulation to maintain securin functions. Our previous reports of SAC bypass and
centriole disengagement (Wise et al., 2006; Holmes et al, 2006; Martino et al.,
2015) suggest securin failure at 120 h, though to determine if securin inhibition of
separase activity was maintained, we directly investigated cleavage of separase
substrates.
Separase is an endopeptidase which cleaves proteins at conserved
recognition sites. When uninhibited by securin and active it cleaves itself, kendrin,
and the cohesin subunit, SCC1. When probing these proteins by western blot, a
full-length protein band can be observed, along with one or more quickly-migrating,
smaller fragments. After 24 h zinc chromate exposure, no change in the
percentage of full length or cleaved separase was observed. After 120 h exposure,
we measured increased protein levels in all separase bands. The increases in
cleaved protein were greater than increases in full-length protein, showing up to
430% and 380% increase for the two cleaved protein bands while full length protein
increased to 170% of control cells. These data indicate separase cleavage is
increased after prolonged Cr(VI) exposure and securin function is not sufficient at
lower levels to control separase activity.
While measurements of increased separase activity were in agreement with
our securin data, another interpretation was that separase activity was increased
by upregulated separase expression. Western blot assay only allows
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measurement of protein fragments that contain the antibody-recognized epitope.
Therefore, any cleaved fragments missing the epitope will not be visualized and
thus it is impossible to measure total protein levels using this method. We used
RT-qPCR to measure separase mRNA expression after Cr(VI) exposure and
better understand if separase levels could be increasing in treated cells. We found
separase expression was reduced by Cr(VI). This outcome could be a potential
feedback response to the loss of securin and supports findings by Pfleghaar et al.
(2005) and Jallepalli et al. (2001) that securin(-/-) cells had depressed separase
protein levels.
Next, we analyzed kendrin cleavage. Kendrin is a separase substrate which
supports centriole engagement. Kendrin is localized to the centrosome and thus
provides a measure of centrosome-specific separase activity. After 24 h Cr(VI)
exposure, no significant changes in kendrin levels were observed. After prolonged
120 h Cr(VI) exposure, full length kendrin protein decreased and cleaved kendrin
levels increased compared to untreated cells, adding evidence for increased
Cr(VI)-induced separase activity. This activity, which is localized to the
centrosomes and directed toward the centriole linkers further implicates centriole
disengagement as a route to centrosome amplification after prolonged Cr(VI)
exposure. There are several potential routes to centrosome amplification, including
failure of cytokinesis, de novo centrosome synthesis, centrosome fragmentation,
and over-duplication (Fukasawa, 2005; Godinho & Pellman, 2014; Tsou & Stearns,
2006a). Our data supports Martino et al. (2015) in proposing centrosome over-
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duplication, by way of premature centriole disengagement, is the most likely cause
of Cr(VI)-induced centrosome amplification.
Cohesin is the best-known separase substrate and has been investigated
widely for its role in sister chromatid cohesion. Cohesin also plays a role in
supporting centriole engagement. Cohesin is a ring complex made of three
subunits and separase specifically targets the SCC1 subunit to open the cohesin
ring. Western blot revealed two bands for SCC1, representing the full-length and
cleaved proteins. Our results indicate prolonged zinc chromate exposure caused
a trend towards increasing SCC1 cleavage in nuclear extracts. Repeated
experiments could further strengthen this trend. SCC1 cleavage is difficult to detect
by western blot because the proportion of cohesin that is cleaved by separase is
relatively small. In interphase cells, cohesin cleavage may occur at sites of DNA
damage (Sun et al., 2006). Centrosome-associated cohesin is a small amount of
protein in the cytoplasm. Even in mitotic cells, when separase is known to play a
critical role in chromatid disjunction, the majority of cohesin along chromatid arms
is released by separase-independent mechanisms, including WAPL protein, and
only the cohesin that remains at the centromeres is cleaved by separase. (Sumara
et al., 2002; Kueng et al., 2006). Thus, separase is responsible for approximately
10% of cohesin cleavage (Sun et al., 2006) and western blot imaging of total SCC1
may be insufficient to demonstrate separase-specific cleavage.
While securin is the main regulator of separase, its function is protected by
compensatory mechanisms in the cell. Studies show separase control can be
retained even after securin knockout (Mei et al., 2001; Pfleghaar et al., 2005),
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leading to questions of how Cr(VI) might circumvent compensation for securin loss.
We investigated the secondary separase inhibitor, cyclin B1. Cyclin B1, in complex
with its partner, cdk1, interacts with separase to inhibit its activity. After prolonged
Cr(VI) exposure we found cyclin B1 protein was also dramatically decreased in
human lung cells, showing Cr(VI) disruption causes a multipronged disruption of
centrosome regulation. Indeed, Cr(VI) carcinogenesis is complex and has been
shown to alter various proteins but the targeting on securin and cyclin B1 indicates
a concentration of effects in pathways of centrosome and chromosome stability
that reach a tipping point in the relatively short period of 120 h.
To confirm the role of securin in Cr(VI)-induced chromosome instability, we
employed siRNA knockdown in human lung cells. Exposure to 24 h Cr(VI) does
not produce effects on securin levels and does not induce numerical chromosome
instability (Wise et al., 2006; Holmes et al., 2010; Martino et al., 2015). We used
securin-targeting siRNAs to experimentally reduce securin levels at 24 h Cr(VI)
exposure times. Our hypothesis was securin reduction will shift the characteristic
120 h phenotype earlier. This hypothesis was supported by the data siRNA
transfection alone did not elevate numerical chromosome instability but addition of
24 h zinc chromate exposure raised levels up to 20.2%, which represented more
than doubling of the control level of 8.5%.
After showing securin is targeted by Cr(VI), protein levels are lost, and
securin function is inhibited, we pursued the mechanism by which securin is
targeted. Cr(VI) can disrupt cellular pathways thorough translational or posttranslational processes, such as altered ubiquitin signaling and protein
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degradation (Bruno et al, 2016). Securin destruction is mediated by ubiquitination
and proteosome degradation. However, our data show loss of securin levels was
not explained by altered degradation rates. Cr(VI) causes cell cycle arrest or delay
(Montiero et al., 2019; Lou et al., 2013; Xiao et al., 2012) so another possibility was
altered protein levels were artifacts of cells becoming stalled in G1 when low levels
of securin are expressed. However, cell cycle analysis confirmed proteins levels
could not be explained by cell cycle effects. RT-qPCR analysis showed Cr(VI)
decreased securin mRNA levels, and thus the mechanism of disruption was
narrowed in to the pre-translational level.
Securin is a novel target of Cr(VI) and while no studies have measured
separase activity after metal exposure, nor specifically in lung cancers, increased
separase activity has been observed in several cancers and it is a topic of
emerging interest in carcinogenesis (Ruppenthal et al., 2018; Gurvits et al., 2017;
Haass et al., 2012). Our data support investigation into securin loss and separase
disruption as a potential step in the Cr(VI) carcinogenic mechanism and as a
potential event in lung cancers.

Cr(VI)-induced alteration of transcription factors
does not explain its action on securin
Mechanisms of Cr(VI)-induced protein disruption are diverse, and thus we
sought to define how Cr(VI) targets securin expression. Cr(VI) has been shown to
inhibit transcription (Raja et al., 2008; Zablon et al., 2019; Wetterhahn et al., 1989)
which aligns with our observations of decreased securin mRNA levels. We tested
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the hypothesis Cr(VI) alters securin-targeting transcription factor levels. Three
transcription factors are reported to promote securin expression, NF-Y, Sp1, and
E2F1 (Zhou et al., 2009, Pappas et al., 2017; Clem et al., 2003). Each of these is
connected with cancer pathways and commonly disrupted in cancer (Gallo et al.,
2021; Yang et al., 2020; Dolfini et al., 2019; Bezzecchi et al., 2019; Vellingiri et al.,
2020; Vizcaino et al., 2015; Hsu et al., 2012; Zhou et al., 2009). No published
studies were identified that address effects of Cr(VI) exposure on NF-Y, though
one study showed cadmium increased NF-Y levels (Ghosh et al., 2020). Raja et
al. (2008) showed Cr(III)-ligand complexes inhibit Sp1 binding at DNA binding sites
and inhibit transcription. These effects were dependent on ligand and
concentration and do not confirm the ability to Cr(III) to disrupt binding in vivo. In
contrast, Kaltreider et al. (1999) observed increased Sp1 binding activity in Cr(VI)exposed melanoma cells, though this effect was transient and only occurred after
1 h exposure. E2F1 dysregulation has been reported after Cr(VI) exposure (Speer
et al., 2021), as well as other metals (Ghosh et al., 2020; Li et al., 2008).
After 24 h and 120 h exposures, Cr(VI) did not induce any changes in whole
cell protein levels of NF-YA or Sp1. Previous findings show Cr(VI) can change
subcellular protein localization, for example sequestering it in the cytoplasm and
thus hindering its function in the nucleus (Speer et al., 2021). Since both NF-YA
and Sp1 are required for securin expression, if either was decreased in the
nucleus, protein levels would decline. Nuclear protein fractions were isolated and
analyzed. Both NF-YA and Sp1 levels increased in the nucleus with prolonged
exposure, indicating Cr(VI) activated nuclear localization of transcription factors.
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We conclude NF-YA and Sp1 levels are not inhibited by Cr(VI) and are actually
increased in the nucleus.
Increased transcription factor levels in the nucleus did not correlate with our
observations of securin mRNA loss. This conclusion does not eliminate the
possibility of Cr(VI) disruption of NF-YA and Sp1 function. It is possible Cr(VI)
affects transcription factor binding or access of transcription machinery to the DNA.
Results from Raja et al. (2008) showed Cr(III) complexes can prevent transcription
factor-DNA binding and depress transcription, though it is unknown if this occurs
at the exposure levels relevant to our study and in human lung cells. Nuclear
binding may be prevented by direct interaction of Cr ions with chromatin, causing
DNA-protein cross-links and DNA breaks (Xu et al., 2004; Zablon et al., 2019).
Indirect Cr actions can include altered DNA and/or histone methylation and
acetylation, preventing access to promoter sites. Cr(VI) globally alters DNA and
histone methylation, impeding gene expression (Lou et al., 2013; Sun et al., 2009;
Schnekenburger et al., 2007). Interestingly, one study examined CpG methylation
in three cancer cell lines and thyroid carcinomas and found no epigenetic
alterations to the securin gene (Hidalgo et al., 2008). This study differs from our
model in that it investigated securin overexpression and the cause of cell
transformation and thyroid may not be due to environmental chemicals. Cr(VI) has
also been shown to alter chromatin architecture, which could disrupt transcription
through displacement of enhancer regions relative to inducible promoters
(VonHandorf et al., 2018; Ovesen et al., 2014).
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We have previously shown whole cell protein levels of the securin-promoter,
E2F1, are decreased in Cr(VI)-exposed human lung cells (Speer et al., 2021).
Speer et al. (2021) showed E2F1 protein loss after prolonged exposure, which
could explain securin loss. In Aim 2, E2F1 knockdown in addition to acute Cr(VI)
exposure was expected to induce securin loss. However, securin levels increased
non-significantly with 24 h Cr(VI) treatment in E2F1 knockdown cells, as in
untransfected cells. This result is in concordance with results from Zhou et al.
(2009) showing E2F1 modulation changes securin levels in p53-deficient cells but
not in p53-competent cells. Knockdown experiments are useful to pinpoint critical
targets, yet the mechanism of Cr(VI) disruption is proving to be multifaceted. Our
results do not exclude the possibility that E2F1 loss plays a role in some way, yet
it is not alone sufficient to explain how Cr(VI) causes dramatic securin loss.
In addition to securin-promoting transcription factors, we investigated two
identified transcription repressors, p53 and KLF6. Whole cell levels and activation
of p53 were not significantly altered. Cr(VI) is reported to increase, stabilize and
phosphorylate p53 (Hill et al., 2008; Hanaoka et al., 1997; Ye et al., 1999).
However, an explanation for this discrepancy is published reports use higher Cr(VI)
levels and often employ cancer cell lines. For example, Ye et al. (1999) used 75500 µM Cr(VI). If completely dissolved, 0.1, 0.2, and 0.3 µg/cm2 is approximately
equivalent to 0.66, 1.34, and 2.00 µM. Chromosome instability and centrosome
amplification are often attributed at least partially to p53 inactivation (Manning et
al., 2014; Fukasawa et al., 1996; Kawamura et al., 2004). In contrast, Luczak et al.
(2019) showed limited activation of p53 in human lung cells and D’Agostini et al.
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(2002) showed marginal p53 induction in rat lungs. Our data show p53 inactivation
or protein loss is not a central effect of Cr(VI).
Prolonged Cr(VI) increased KLF6 nuclear levels, which may partially
explain securin loss, however this effect was only seen at the two highest
concentrations and does not fully explain securin loss. Securin targeting by KLF6
is reported in two known studies (Chen et al., 2013; Lee at al., 2010) and has been
shown to be targeted by DNA-damaging agents (Gehrau et al., 2011). KLF6 has
not been shown to be altered by metal exposure, though other kruppel-like family
members are (Sharma et al., 2013; Zhu et al., 2018). While KLF6 nuclear reduction
is not the sole source of securin decrease, it could be a contributing factor and
KLF6 loss at prolonged and higher concentrations may have implications for Cr(VI)
carcinogenesis.

Cr(VI)-induced securin loss is not caused by
differential miRNA expression
Cr(VI)-induced decrease in securin mRNA was not fully explained by
transcription factor disturbances. Another mechanism for mRNA loss is miRNA
regulation. Typically, miRNAs alter gene expression by inhibiting translation of their
target mRNAs. Few reports have investigated Cr(VI) effects on miRNA. Li et al.
(2014) showed plasma miR-3940-5p in chromate workers correlated with
micronuclei frequency and levels of DNA repair proteins XRCC2 and BRCC3.
Dioni et al. (2016) analyzed 377 miRNAs from human peripheral blood samples
and identified nine miRNAs with negative correlations to urinary Cr. These studies
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demonstrate human Cr exposure can induce changes in miRNAs. Other
carcinogenic metals, such as arsenic and cadmium, have also been shown to
cause miRNA alterations (He at al., 2013; Humphries et al., 2017; Wang et al.,
2020; Liu et al., 2015; Gonzalez et a., 2015). We used miRNA-seq to assess global
miRNA expression after 24, 72, and 120h in human lung cells and found Cr(VI) upand down-regulated miRNAs at each concentration and time point. Predicted
securin-targeting miRNAs were not altered in our study and thus observed miRNA
changes do not explain securin loss. However, several proteins involved in
centrosome and chromosome maintenance are predicted targets of Cr(VI)induced miRNA alteration. Notably, Sp1, NF-Y subunits, E2F1 and KLF6 are
putative targets for miRNAs down-regulated by Cr(VI). MiRNA downregulation
could explain the increase of Sp1, NF-YA, and KLF6 we measured, though it is
incongruent with E2F1 loss previously observed (Speer et al., 2021). PP2A, SKP1
and CUL1 are involved in degradation of securin and cyclin B1. Our data showed
potential miRNA interactions could be downregulated by Cr(VI), theoretically
increasing degradation. Our data showed securin degradation rates were
unchanged, but cyclin B1 is degraded by the same pathway and thus miRNA
regulation could play a role in cyclin B1 loss. Overall, we found after 72 h and 120
h Cr(VI) exposure, miRNAs were more frequently down-regulated than upregulated.
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Whales resist Cr(VI)-induced numerical chromosome instability through
retention of normal securin and centrosome regulation
Cr(VI) is a widespread environmental carcinogen. The One Environmental
Health philosophy acknowledges humans and wildlife are exposed to the same
environmental contaminants and research into toxic effects on one species is
informative to other species and to ecosystem health (Pérez and Wise, 2018). In
Aim 3 we showed whale cells exposed to zinc chromate experience cytotoxicity
after acute and prolonged exposure. Sperm whale skin cells had lower survival
rates compared to bowhead whale lung cells, which may be explained by
differences in Cr uptake. It is unknown whether this is due to the difference in
species, organ, or individual variation. Xie et al. (2015) show human skin cells are
more sensitive to Cr(VI) toxicity. Peto (1977) considered a line of reasoning to
explain cancer differences among various organ types, suggesting perhaps certain
cells might be better equipped to cope with proliferative changes, given their
inherent differences in life cycle.
Several published findings demonstrate whale cells are susceptible to
Cr(VI)-induced cytotoxicity and genotoxicity (Wise et al., 2008; Li Chen et al., 2009;
Wise et al., 2011; Wise et al., 2015). While bowhead whales experienced relatively
lower levels of cytotoxicity than sperm whale cells, they nevertheless displayed
DNA double strand breaks and chromosome damage, indicating toxic effects of
Cr(VI) are induced at the intracellular levels achieved in bowhead whale cells.
Remarkably, as opposed to human lung cells, pressure of Cr(VI) exposure and
DNA damage did not decrease securin protein levels in whale lung cells, even at
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prolonged timepoints. We measured SAC bypass as a proxy for securin function
and found no increase in metaphase centromere defects in whale cells. Browning
et al. (2017) showed North Atlantic right whale cells resisted loss of RAD51 protein,
in contrast to the human cell response (Browning et al., 2016; Qin et al., 2014).
Thus, evidence suggests whale cells maintain normal protein expression under
Cr(VI). It would be insightful to learn if this ability is due to differences in epigenetic
control.
We propose securin loss leads to centrosome amplification in human lung
cells. We measured centrosome amplification in whale cells and found no increase
in centrosome amplification in either mitotic or interphase cells. We propose Cr(VI)induced centrosome amplification drive numerical chromosome instability in
human lung cells. Whale cells had no increase in aneuploidy after 24 or 120 h.
This is the first study to consider centrosomes or numerical chromosome instability
in whale cells and aligns with Browning et al. (2017) in showing carcinogenic
pathways are avoided in whale cells despite Cr(VI) exposure.
Our results support the hypothesis whale cells are resistant to Cr(VI)induced structural and numerical chromosome instability. These data are the first
to consider numerical chromosome instability and centrosome amplification in
whale cells and contribute to mechanistic insights in Cr(VI) genotoxicity. Previous
research showed whale cells resist Cr(VI)-induced disruption to homologous
repair, making them resistant to structural chromosome instability (Browning et al.,
2017) and this finding helped further solidify the essential role of homologous
repair in Cr(VI) genotoxicity in human cells. Likewise, by showing prevention of
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securin loss and centrosome amplification in whale cells correlates to resistance
against numerical chromosome instability, we promote the importance of securin
function and centrosome maintenance to Cr(VI) toxicity to humans.

Conclusions
This dissertation investigates a hypothesis of molecular mechanisms
central to Cr(VI)-induced centrosome amplification. Together, these data show
Cr(VI) targets securin expression, leading to loss of mRNA levels, protein levels,
and compromises securin’s inhibitory function of separase. Loss of separase
inhibition leads to elevated cleavage of its substrates, including centriole linkers.
These outcomes support the conclusion premature cleavage of centriole linkers
causes centriole disengagement that promotes centrosome overduplication.
Supernumerary centrosomes result in numerical chromosome instability, which
confers genotypic plasticity advantageous to Cr(VI)-induced transformation and
carcinogenesis.
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CHAPTER 5: FUTURE DIRECTIONS

This dissertation describes new findings in the carcinogenic mechanism of
Cr(VI) and specifically identifies securin as a novel target that leads to centrosome
amplification and numerical chromosome instability. Our results introduce new
directions for research that enhance the field of knowledge about cancer and metal
toxicology. The following suggestions highlight future work which could build upon
our understanding of the mechanisms proposed.
In Aim 1 we report prolonged Cr(VI) exposure caused increased kendrin
cleavage, indicating elevated separase activity. We also measured cleavage of the
cohesin subunit, SCC1. However, western blots showed variable results in kendrin
cleavage product bands, which might be explained by variable phosphorylation. In
the case of SCC1 western blots, the amount of cohesin product specifically
cleaved by separase is actually a low percentage of total cohesin. It is possible to
synthesize reporter peptides that would be useful in defining separase activity on
kendrin and SCC1 with greater resolution. Peptides constructed to mimic separase
cleavage sites can be integrated with fluorescent dyes to generate a colorchanging signal upon cleavage activity (Agircan et al., 2014; Basu et al., 2009;
Haass et al., 2015; Zhang et al., 2014). These reporters can be designed for use
in lysates and measured by spectrometry. Addition of dyes for cell uptake control
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allows reporters to be measured in flow cytometry and, theoretically, in adherent
cells. Reporter peptides offer a more sensitive measure of separase activity. Plus,
with localization sequences, they can indicate separase activity specific to the
centromeres or centrosomes. These reporters have never been used in Cr(VI)
research and would be useful not only to confirm alterations in separase activity
but could indicate timing and cellular location of cleavage.
In Aim1 we show securin knockdown increased 24 h Cr(VI)-induced
numerical chromosome instability above untransfected Cr(VI)-exposed cells. The
increase was in the same direction, but less severe than cells exposed to 120 h
Cr(VI). Given that the secondary separase inhibitor, cyclin B1, is also reduced after
120 h exposure, it is likely that the magnitude of Cr(VI)-induced effects is a
combination of factors. Future studies that knockdown both securin and cyclin B1,
and cyclin B1 only, can show the relative importance of securin loss in the context
of Cr(VI) exposure.
In Aim 2 we measured effects on two transcription factors that promote
securin transcription. We found whole cell levels were not significantly altered, and
nuclear levels were induced. Thus, transcription factor levels are not implicated in
securin loss. Yet, other effects on transcription factor function could be occurring.
To further address this question, chromatin immunoprecipitation can determine if
NF-YA and Sp1 are binding to the securin promoter region. In the case binding is
lost, epigenetic assays can then direct research to answer how Cr(VI) may alter
DNA methylation, histone modifications, or chromatin architecture. Broadly, Cr(VI)
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is known to alter epigenetics, but if these effects play a role in centrosome
amplification is unknown.
Loss of KLF6 was observed in nuclear protein fractions at the highest
concentrations and exposure times. Whether KLF6 is a contributing factor to
securin loss is not completely understood based on our results. Securin
measurement after KLF6 knockdown would help clarify the role of KLF6 in Cr(VI)induced securin loss.
No securin-targeting miRNAs were found to be altered in our miRNA-seq
data. However, several other proteins associated with centrosome maintenance
and chromosome stability are potential targets of Cr(VI)-altered miRNAs. Future
work exploring post-transcriptional deregulation of these genes could break
ground in discovering key miRNAs involved in Cr(VI)-induced numerical
chromosome instability. Additionally, measuring mRNA stability would help focus
research on the precise level of expression that is intercepted.
In Aim 3, whale cells are shown to be resistant to Cr(VI)-induced securin
loss, centrosome amplification, and chromosome instability. These data support
earlier findings that show proteins key to homologous recombination repair are
retained in Cr(VI)-exposed whale cells. Our work shows species comparisons help
elucidate the mechanisms of toxicity in humans as well. Examining DNA
methylation, transcription binding, and mRNA stability in whale cells would help
identify how whale cells avoid a toxic fate and aid understanding Cr(VI)
carcinogenesis. Wildlife work can be hampered by lack of appropriate reagents
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such as antibodies, but the sperm whale genome is highly annotated and protein
and gene sequences can be identified in many cases.
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APPENDIX: ABBREVIATIONS
APC: Anaphase promoting complex
APC/C: Anaphase promoting complex/cyclosome
ATSDR: Agency for Toxic Substances and Disease Registry
CIN: Chromosome instability
Cr(VI): Hexavalent chromium
IARC: International Agency for Research on Cancer
kDa: Kilodalton
mRNA: Messenger RNA
miRNA: MicroRNA
NIOSH: National Institute for Occupational Safety and Health
OSHA: Occupational Safety and Health Administration
RNA: Ribonucleic acid
RT-qPCR: Real-time quantitative polymerase chain reaction
SAC: Spindle assembly checkpoint
siRNA: Small interfering RNA
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Particulate Hexavalent Chromium Targets RAD51 in Human Lung Epithelial
Cells, Leading to Increased Chromosome Instability, a Driver of
Carcinogenesis. Presented at Research!Louisville, Louisville, KY, October
2021.
14. Cahill, C.R., Toyoda, J.H., Wise, S.S., Wise, Sr., J.P. Securin Deregulation
Persists After Chronic Hexavalent Chromium Exposure. Presented at
Research!Louisville, Louisville, KY, October 2021.

Oral Presentations
1. Three-Minute Thesis: “Securin Disruption and Chromosome Instability Persist
After Chronic Hexavalent Chromium Exposure.” Ohio Valley Society of
Toxicology Annual Meeting, November 2021.
2.

Platform: “Chronic Hexavalent Chromium Exposure Causes Persistent Securin
Disruption and Induces Chromosome Instability.” Environmental Mutagenesis
and Genomic Society (EMGS) 2021 Annual Meeting, September 2021.

3.

Guest Lecture: “A Whale Tale: The Story Whale Biopsies Tell About Global
Marine Pollution.” University of Southen Mississippi Gulf Coast Research
Laboratory, May 2021.

4.

Poster Talk: “Particulate Hexavalent Chromium Targets Securin, Disrupts
Centriole Engagement, and Induces Chromosome Instability.” Genetic
Toxicology Association Annual Meeting, May 2021.

5.

Oral Presentation: “Divided We Fall: Particulate Hexavalent Chromium
Targets Securin Driving Premature Centriole Separation.” Society of
Toxicology Metals Specialty Section Reception, March 2021

6.

Three-Minute Thesis: “When Your Chainsaw Loses Its Safety Lock: A
Hypothesis for Metal-Induced Lung Cancer.” Society of Toxicology, March
2021

7.

Three-Minute Thesis: “When Your Chainsaw Loses Its Safety Lock: a
Hypothesis for Metal-Induced Lung Cancer.” University of Louisville, March
2021

8.

Seminar: “Divided We Fall: Particulate Hexavalent Chromium Targets
Securin and Drives Premature Centriole Separation.” Department of
Pharmacology and Toxicology, January 2021.
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9.

PhD Platform: “Prolonged Particulate Hexavalent Chromium Exposure
Disrupts Centrosome Regulation Proteins and Causes Centrosome
Amplification.” Ohio Valley Society of Toxicology (OVSOT) Annual Meeting,
November 2020.

10. PhD Platform: “Hexavalent Chromium Decreases Securin Expression and
Increases Separase Substrate Cleavage in Human Lung Cells.” Ohio Valley
Society of Toxicology (OVSOT) Student/Postdoc Meeting, August 2020.
11. Seminar: “Investigating the Role of Securin in Hexavalent Chromium
Carcinogenesis.” Department of Pharmacology and Toxicology, January
2020.
12. Oral Presentation: “Particulate Hexavalent Chromium Does Not Induce
Centrosome Amplification in Sperm Whale and Bowhead Whale Cells: Metals
Carcinogenesis from a One Environmental Health Perspective.” Graduate
Student Regional Research Conference, February 2019.
13. PhD Platform: “Particulate Hexavalent Chromium Does Not Induce
Centrosome Amplification in Sperm Whale and Bowhead Whale Cells: Metals
Carcinogenesis from a One Environmental Health Perspective.” Ohio Valley
Regional Chapter of the Society of Toxicology, Annual Meeting, November
2018.
14. Master Thesis Defense and Ph.D. Proposal: “Molecular Mechanisms of
Particulate Hexavalent Chromium-Induced Centrosome Amplification.”
Department of Pharmacology and Toxicology Seminar, June 2018.
15. Seminar: “Mechanisms of Hexavalent Chromium-Induced Centriole
Disengagement and Centrosome Amplification.” Department of
Pharmacology and Toxicology, March 2017.

Meetings Attended (current year and previous 5 years)
2017 Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Research!Louisville
Graduate Student Regional Research Conference
2018 Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Research!Louisville
Graduate Student Regional Research Conference
2019 Annual Meeting of the Society of Toxicology (SOT)
Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
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Research!Louisville
Graduate Student Regional Research Conference
2020 Annual Meeting of the Society of Toxicology (SOT)
Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Summer Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
American Society for Cell Biology
University of Rhode Island STEEP (Sources, Transport, Exposure &
Effects of PFAS)
Graduate Student Regional Research Conference
2021 Annual Meeting of the Society of Toxicology (SOT)
Annual Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Summer Meeting, Ohio Valley Chapter of the Society of Toxicology
(OVSOT)
Annual Meeting of Genetic Toxicology Association (GTA)
Annual Meeting of the Environmental Mutagenesis and Genomics Society
(EMGS)
NIEHS Superfund Research Program Annual Meeting
2022 Annual Meeting of the Society of Toxicology (SOT)
Honors and Awards
2022 Environmental Carcinogenesis Merit Award, Carcinogenesis Specialty
Section, Society of Toxicology
2021 Research Grant, University of Louisville, $500 for custom siRNAs
2021 First Place, “Tox on the Clock” Competition, Ohio Valley Society of
Toxicology Annual Meeting
2021 Best Graphical Abstract, “Tox on the Clock” Competition, Ohio Valley
Society of Toxicology Annual Meeting
2021 Environmental Mutagenesis and Genomics Society (EMGS) Emerging
Scientist Award
2021 Exemplary Abstract Award, Genetic Toxicology Association Annual
Meeting
2021 First Place, Graduate Student Abstract/Poster Award, Metals Specialty
Section, Society of Toxicology Annual Meeting
2021 First Place, Three Minute Thesis (3MT), University of Louisville
2020 Graduate Student Poster Award, NIEHS Superfund Research Program
Annual Meeting
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2020 First Place, PhD Platform, Ohio Valley Society of Toxicology Annual
Meeting
2020 First Place, PhD Platform, Ohio Valley Society of Toxicology
Student/Postdoc Meeting
2020 Second Place, Dharm V. Singh Graduate Student Award, Carcinogenesis
Specialty Section, Society of Toxicology
2020 First Place, PhD Poster Session, Graduate Student Council Regional
Research Conference
2020 Travel Award, University of Louisville, $350 for travel to 2020 Annual
Meeting of the Society of Toxicology
2019 First Place, “Tox on the Clock” Competition, Ohio Valley Society of
Toxicology Annual Meeting
2019 Travel Award, University of Louisville, $350 for travel to 2019 Annual
Meeting of the Society of Toxicology
2018 Second place, PhD Platform, Ohio Valley Society of Toxicology Annual
Meeting
2018 Research Grant, University of Louisville, $500 for whale sample collection
2017 Research Grant, University of Louisville, $500 for whale sample collection
Leadership and Service Positions
2021-2022

2020-2021

Chair – Communications Subcommittee, Society of Toxicology,
Graduate Student Leadership Committee
Graduate Student Representative – Metals Specialty Section,
Society of Toxicology
Graduate Student Representative – Ohio Valley Regional Chapter,
Society of Toxicology
Secretary – Communications Subcommittee, Society of Toxicology
Graduate Student Leadership Committee
Graduate Student Representative – Metals Specialty Section,
Society of Toxicology
Director of Finance – Graduate Student Council, University of
Louisville (UofL)
Chair – Graduate Student Council Research Grant Committee,
UofL
Student Senator – Student Government Association & Senate
Appropriations Committee, UofL
Department Representative – Graduate Student Council, UofL
President – Department of Pharmacology and Toxicology Student
Organization
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2019-2020

Department Representative – Graduate Student Council, UofL
Committee Member – Graduate Student Council Research Grant
Committee, UofL
President – Department of Pharmacology and Toxicology Student
Organization, UofL
Secretary & Social Media Coordinator – Science Policy Outreach
Group, UofL
2016 – 2019 Class Representative – Department of Pharmacology and
Toxicology Student Organization
Professional and Academic Memberships
2016 – Present

Graduate Student Member – Science Policy Outreach
Group, UofL

2016 – Present

Graduate Student Member – Society of Toxicology
Ohio Valley Regional Chapter, Metals Specialty Section,
Carcinogenesis Specialty Section,
Women in Toxicology Special Interest Group

Research Mentorship Experience
2021 Undergraduate: Caitlin Cahill
2019 Visiting Scholar: Emma Martinez Lopez, PhD
2019 Visiting Master’s Student: Chester Gan
2018 Undergraduate: Mariah Geisen
Volunteer and Community Work
2022 Science Fair Mentor, Louisville Regional Science and Engineering Fair
Charlotte Connally, First Place Cellular and Molecular Biology,
Middle School
2021 Judge, Louisville Regional Science and Engineering Fair
Judge, Wyoming State Science Fair
2020 Science Fair Mentor, Central High School
Science Fair Mentor, Kentucky Science and Engineering Fair
Judge, Louisville Regional Science and Engineering Fair
Science Fair Mentor, Central High School
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2019 Science Fair Mentor, Central High School
Facilitator Assistant, Girls Rule STEM+Health Summit
Continuing Education Course Volunteer, Annual Meeting of the
Society of Toxicology
Science Fair Ambassador, Louisville Regional Science and
Engineering Fair
Science Fair Mentor, Central High School
Field Work
2017-2019

Alligator sampling expeditions at Kennedy Space Center and other
locations in Florida.

2018-2021

Whale biopsy collection in the Gulf of Maine

2011-2012

Fish sampling in the Bering Sea, Gulf of Alaska,
North Pacific Ocean

Techniques and Skills
Cell culture
Western blot analysis
Immunofluorescence
Confocal microscopy
Chromosome analysis
Mitotic stage analysis
Atomic absorption spectroscopy
Single cell gel electrophoresis (“Comet” assay)
Flow cytometry
RT-qPCR
RNA sequencing
Rat chemical inhalation exposures
Rat and mouse lung inflation, anesthesia, euthanasia, handling
Tissue staining (hematoxylin and eosin, picosirius red)
Fluorescence In Situ Hybridization (FISH)
Wildlife primary cell line establishment
Whale ID and biopsy processing
Alligator blood, skin, and urine sampling
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